Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes,db,module
GABAergic synapse,7/90,3.36103616837185e-07,2.52077712627889e-05,0,0,17.9711102474414,267.874607926962,SLC38A1;SLC32A1;GAD1;GAD2;ABAT;SLC6A1;GABRG3,KEGG_2019_Mouse,green
Butanoate metabolism,3/27,0.0003251243529193,0.0121921632344754,0,0,25.6134020618557,205.708988323138,GAD1;GAD2;ABAT,KEGG_2019_Mouse,green
beta-Alanine metabolism,3/32,0.0005414210691078,0.0135355267276957,0,0,21.1919658727337,159.391414042061,GAD1;GAD2;ABAT,KEGG_2019_Mouse,green
"Alanine, aspartate and glutamate metabolism",3/37,0.0008329373632247,0.0156175755604634,0,0,18.0709520921771,128.133027538084,GAD1;GAD2;ABAT,KEGG_2019_Mouse,green
Taurine and hypotaurine metabolism,2/11,0.0013218400851343,0.0198276012770146,0,0,45.1043083900227,298.984305122014,GAD1;GAD2,KEGG_2019_Mouse,green
Synaptic vesicle cycle,3/77,0.0067890554235684,0.084863192794605,0,0,8.28615213151296,41.3681460172482,SLC32A1;SLC6A1;CPLX1,KEGG_2019_Mouse,green
Neuroactive ligand-receptor interaction,6/348,0.0080629517919479,0.086388769199442,0,0,3.65024262784621,17.595905383705,SST;NPY;GRIK1;GRIK2;GABRG3;ADRA1A,KEGG_2019_Mouse,green
Nicotine addiction,2/40,0.0170631829128301,0.159967339807783,0,0,10.6670247046187,43.4236674606069,SLC32A1;GABRG3,KEGG_2019_Mouse,green
Glutamatergic synapse,3/114,0.0195542061325189,0.162951717770991,0,0,5.51379214265812,21.6943728553258,SLC38A1;GRIK1;GRIK2,KEGG_2019_Mouse,green
Adrenergic signaling in cardiomyocytes,3/148,0.0381645668105914,0.270326584310548,0,0,4.21365090650551,13.7611423922677,CACNA2D2;ATP1A3;ADRA1A,KEGG_2019_Mouse,green
Type I diabetes mellitus,2/69,0.0467626402187707,0.270326584310548,0,0,6.04112092598233,18.5019639390654,GAD1;GAD2,KEGG_2019_Mouse,green
Adherens junction,2/72,0.0504637828415357,0.270326584310548,0,0,5.78134110787172,17.265971584774,PTPRM;SORBS1,KEGG_2019_Mouse,green
Gastric acid secretion,2/74,0.0529880944930012,0.270326584310548,0,0,5.62018140589569,16.5103396024628,SST;ATP1A3,KEGG_2019_Mouse,green
cGMP-PKG signaling pathway,3/172,0.0552127694919147,0.270326584310548,0,0,3.61087049350332,10.4591067236381,KCNMB2;ATP1A3;ADRA1A,KEGG_2019_Mouse,green
Cardiac muscle contraction,2/78,0.058168160710821,0.270326584310548,0,0,5.32330827067669,15.1417092906877,CACNA2D2;ATP1A3,KEGG_2019_Mouse,green
Salivary secretion,2/78,0.058168160710821,0.270326584310548,0,0,5.32330827067669,15.1417092906877,ATP1A3;ADRA1A,KEGG_2019_Mouse,green
Axon guidance,3/180,0.0615800766393562,0.270326584310548,0,0,3.44626943910536,9.60618964872885,DPYSL5;TRPC4;SEMA4G,KEGG_2019_Mouse,green
ECM-receptor interaction,2/83,0.0648783802345316,0.270326584310548,0,0,4.99344923154447,13.6582862458477,RELN;SV2A,KEGG_2019_Mouse,green
Insulin secretion,2/86,0.0690235124413976,0.272461233321307,0,0,4.81438289601555,12.8703286595916,KCNMB2;ATP1A3,KEGG_2019_Mouse,green
Morphine addiction,2/92,0.0775653030615549,0.290869886480831,0,0,4.49206349206349,11.484567093173,SLC32A1;GABRG3,KEGG_2019_Mouse,green
Glycerophospholipid metabolism,2/97,0.0849237360045433,0.303299057159083,0,0,4.25456498388829,10.491764264828,ACHE;TAZ,KEGG_2019_Mouse,green
cAMP signaling pathway,3/211,0.0892518307965823,0.304267604988349,0,0,2.92803330689929,7.0749873945873,SST;NPY;ATP1A3,KEGG_2019_Mouse,green
Pancreatic secretion,2/105,0.0971124998083677,0.313394093457315,0,0,3.92252823459481,9.1468854610462,ATP1A3;RAB27B,KEGG_2019_Mouse,green
PI3K-Akt signaling pathway,4/357,0.104069367309126,0.313394093457315,0,0,2.30724740321058,5.22060318221224,MAGI1;RELN;ERBB4;KIT,KEGG_2019_Mouse,green
Proximal tubule bicarbonate reclamation,1/22,0.104464697819105,0.313394093457315,0,0,9.56180856180856,21.5992275397069,ATP1A3,KEGG_2019_Mouse,green
Mucin type O-glycan biosynthesis,1/28,0.131029255394866,0.377969005946728,0,0,7.43471754582866,15.1098341340557,GALNTL6,KEGG_2019_Mouse,green
Propanoate metabolism,1/31,0.144017471501311,0.400048531948087,0,0,6.69023569023569,12.9644769200402,ABAT,KEGG_2019_Mouse,green
Vascular smooth muscle contraction,2/140,0.155166268510966,0.415623933511515,0,0,2.92250813368826,5.44538676806967,KCNMB2;ADRA1A,KEGG_2019_Mouse,green
Retrograde endocannabinoid signaling,2/150,0.172791328093857,0.433951644829064,0,0,2.72366243794815,4.7818540898178,SLC32A1;GABRG3,KEGG_2019_Mouse,green
Aldosterone-regulated sodium reabsorption,1/38,0.173580657931626,0.433951644829064,0,0,5.42260442260442,9.49559255823113,ATP1A3,KEGG_2019_Mouse,green
MAPK signaling pathway,3/294,0.1823346342158,0.441132179554355,0,0,2.08406844510575,3.54690032572311,ERBB4;KIT;CACNA2D2,KEGG_2019_Mouse,green
Carbohydrate digestion and absorption,1/43,0.19407611900782,0.445880905762885,0,0,4.77585377585378,7.83003533696715,ATP1A3,KEGG_2019_Mouse,green
Mineral absorption,1/44,0.1981144149655,0.445880905762885,0,0,4.6645525017618,7.55149331126355,ATP1A3,KEGG_2019_Mouse,green
Glycosphingolipid biosynthesis,1/45,0.202132677279174,0.445880905762885,0,0,4.55831037649219,7.28796784173202,ST8SIA1,KEGG_2019_Mouse,green
Cell adhesion molecules (CAMs),2/170,0.208900201139448,0.447643288155959,0,0,2.39698736637512,3.75343927524843,CNTNAP2;PTPRM,KEGG_2019_Mouse,green
N-Glycan biosynthesis,1/50,0.221926911560385,0.448242335795201,0,0,4.09214594928881,6.16034588762116,MGAT4C,KEGG_2019_Mouse,green
Fanconi anemia pathway,1/51,0.225827021656465,0.448242335795201,0,0,4.01010101010101,5.96697401593565,REV3L,KEGG_2019_Mouse,green
Endocrine and other factor-regulated calcium reabsorption,1/55,0.241234861655302,0.448242335795201,0,0,3.71230826786382,5.27884403782842,ATP1A3,KEGG_2019_Mouse,green
Calcium signaling pathway,2/189,0.243858065056649,0.448242335795201,0,0,2.1513696387646,3.03594597725027,ERBB4;ADRA1A,KEGG_2019_Mouse,green
"Valine, leucine and isoleucine degradation",1/56,0.245039143568043,0.448242335795201,0,0,3.64462809917355,5.12557648253206,ABAT,KEGG_2019_Mouse,green
Regulation of lipolysis in adipocytes,1/56,0.245039143568043,0.448242335795201,0,0,3.64462809917355,5.12557648253206,NPY,KEGG_2019_Mouse,green
Inflammatory bowel disease (IBD),1/59,0.256339055642632,0.457748313647557,0,0,3.45559038662487,4.70393718537215,MAF,KEGG_2019_Mouse,green
Central carbon metabolism in cancer,1/64,0.274801310842782,0.460345549667825,0,0,3.18053551386885,4.10831982313615,KIT,KEGG_2019_Mouse,green
Rap1 signaling pathway,2/209,0.280904713771957,0.460345549667825,0,0,1.94153603470374,2.46524550660258,MAGI1;KIT,KEGG_2019_Mouse,green
Aminoacyl-tRNA biosynthesis,1/66,0.282058502576368,0.460345549667825,0,0,3.08236208236208,3.90116313048372,SARS,KEGG_2019_Mouse,green
Acute myeloid leukemia,1/69,0.29280968888067,0.460345549667825,0,0,2.94592988710636,3.61828655610275,KIT,KEGG_2019_Mouse,green
Adipocytokine signaling pathway,1/71,0.299888438313403,0.460345549667825,0,0,2.86147186147186,3.44619860155019,NPY,KEGG_2019_Mouse,green
Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.303401461859655,0.460345549667825,0,0,2.82102717313985,3.36463457832852,CACNA2D2,KEGG_2019_Mouse,green
Bile secretion,1/72,0.303401461859655,0.460345549667825,0,0,2.82102717313985,3.36463457832852,ATP1A3,KEGG_2019_Mouse,green
Thyroid hormone synthesis,1/73,0.306897033111884,0.460345549667825,0,0,2.78170594837262,3.28587063696556,ATP1A3,KEGG_2019_Mouse,green
ErbB signaling pathway,1/84,0.344220716526821,0.487142565640376,0,0,2.41170743580382,2.57201895784243,ERBB4,KEGG_2019_Mouse,green
PPAR signaling pathway,1/85,0.347513436866072,0.487142565640376,0,0,2.38287638287638,2.51858583349566,SORBS1,KEGG_2019_Mouse,green
Hypertrophic cardiomyopathy (HCM),1/86,0.350789788685405,0.487142565640376,0,0,2.35472370766488,2.46673350535558,CACNA2D2,KEGG_2019_Mouse,green
Th1 and Th2 cell differentiation,1/87,0.354049852499014,0.487142565640376,0,0,2.3272257458304,2.41639933353241,MAF,KEGG_2019_Mouse,green
Dilated cardiomyopathy (DCM),1/90,0.363733115678147,0.487142565640376,0,0,2.24843945068664,2.27392523969427,CACNA2D2,KEGG_2019_Mouse,green
Protein digestion and absorption,1/90,0.363733115678147,0.487142565640376,0,0,2.24843945068664,2.27392523969427,ATP1A3,KEGG_2019_Mouse,green
Hematopoietic cell lineage,1/94,0.376420920115876,0.495290684362995,0,0,2.15129792549147,2.10191981526176,KIT,KEGG_2019_Mouse,green
Melanogenesis,1/100,0.394984420817951,0.509809121688995,0,0,2.02030405060708,1.87667852610055,KIT,KEGG_2019_Mouse,green
Aldosterone synthesis and secretion,1/102,0.401049842395342,0.509809121688995,0,0,1.98009800980098,1.80915528558786,ATP1A3,KEGG_2019_Mouse,green
Cholinergic synapse,1/113,0.433349218837219,0.539795566916802,0,0,1.78463203463203,1.4923295915181,ACHE,KEGG_2019_Mouse,green
Thyroid hormone signaling pathway,1/115,0.439033727758999,0.539795566916802,0,0,1.7531454899876,1.44315262186649,ATP1A3,KEGG_2019_Mouse,green
AMPK signaling pathway,1/126,0.469304042324134,0.567706502811453,0,0,1.5979797979798,1.20887881651748,ADRA1A,KEGG_2019_Mouse,green
Dopaminergic synapse,1/135,0.492863296366116,0.586742019483472,0,0,1.48997437057139,1.05419178131578,SCN1A,KEGG_2019_Mouse,green
Insulin signaling pathway,1/139,0.502998845735877,0.589451772346731,0,0,1.44649392475479,0.993983474661611,SORBS1,KEGG_2019_Mouse,green
Breast cancer,1/147,0.522672127159014,0.595492498098044,0,0,1.36668050366681,0.886703567337748,KIT,KEGG_2019_Mouse,green
Phospholipase D signaling pathway,1/149,0.527468747150282,0.595492498098044,0,0,1.34807534807535,0.862317510620557,KIT,KEGG_2019_Mouse,green
Oxytocin signaling pathway,1/154,0.539252532966754,0.595492498098044,0,0,1.30369049976893,0.805121832204194,CACNA2D2,KEGG_2019_Mouse,green
Human papillomavirus infection,2/360,0.53991319827556,0.595492498098044,0,0,1.11401208528104,0.686617891179883,MAGI1;RELN,KEGG_2019_Mouse,green
Tight junction,1/167,0.568546217907677,0.617985019464866,0,0,1.20080321285141,0.678060757672765,MAGI1,KEGG_2019_Mouse,green
Transcriptional misregulation in cancer,1/183,0.6020794872594,0.645085164920786,0,0,1.09435009435009,0.555235815206858,MAF,KEGG_2019_Mouse,green
Alcoholism,1/199,0.633030530285215,0.65793312216109,0,0,1.00510152025304,0.459569228815331,NPY,KEGG_2019_Mouse,green
Focal adhesion,1/199,0.633030530285215,0.65793312216109,0,0,1.00510152025304,0.459569228815331,RELN,KEGG_2019_Mouse,green
Proteoglycans in cancer,1/203,0.640388238903461,0.65793312216109,0,0,0.984998499849985,0.438994784726488,ERBB4,KEGG_2019_Mouse,green
Ras signaling pathway,1/233,0.691107962443606,0.700447259233385,0,0,0.85632183908046,0.316376004340495,KIT,KEGG_2019_Mouse,green
Pathways in cancer,1/535,0.93400856626885,0.93400856626885,0,0,0.366322400030265,0.0250087090710907,KIT,KEGG_2019_Mouse,green
Alzheimer disease,5/175,0.0018661950599364,0.181511659500816,0,0,6.10835913312694,38.3840348237791,COX8A;RTN3;GSK3B;CALM1;COX5B,KEGG_2019_Mouse,turquoise
Oxidative phosphorylation,4/134,0.0045997805345406,0.181511659500816,0,0,6.33653846153846,34.1016448693132,COX8A;ATP6V0B;ATP6V1B2;COX5B,KEGG_2019_Mouse,turquoise
Synaptic vesicle cycle,3/77,0.0067890554235684,0.181511659500816,0,0,8.28615213151296,41.3681460172482,ATP6V0B;RAB3A;ATP6V1B2,KEGG_2019_Mouse,turquoise
Cardiac muscle contraction,3/78,0.0070353356395665,0.181511659500816,0,0,8.17525773195876,40.5231982940018,COX8A;ATP1B1;COX5B,KEGG_2019_Mouse,turquoise
Salmonella infection,3/78,0.0070353356395665,0.181511659500816,0,0,8.17525773195876,40.5231982940018,PKN2;WASL;PFN2,KEGG_2019_Mouse,turquoise
Choline metabolism in cancer,3/99,0.0134550429542985,0.289283423517418,0,0,6.38015463917526,27.4882665567256,WASL;GPCPD1;DGKI,KEGG_2019_Mouse,turquoise
Mineral absorption,2/44,0.0204294838615153,0.376486202590782,0,0,9.6491739552964,37.5427757402553,FTH1;ATP1B1,KEGG_2019_Mouse,turquoise
Spliceosome,3/132,0.0285811776295865,0.460871489277083,0,0,4.74011028530328,16.8511247836,TRA2A;HNRNPU;SRSF10,KEGG_2019_Mouse,turquoise
Non-alcoholic fatty liver disease (NAFLD),3/151,0.0401225074756248,0.501100499011177,0,0,4.12761214823071,13.2736486939267,COX8A;GSK3B;COX5B,KEGG_2019_Mouse,turquoise
Endocytosis,4/269,0.0460978013691878,0.501100499011177,0,0,3.0872641509434,9.49948099007502,ZFYVE9;WASL;SMAP1;ARF5,KEGG_2019_Mouse,turquoise
Gastric acid secretion,2/74,0.0529880944930012,0.501100499011177,0,0,5.62018140589569,16.5103396024628,ATP1B1;CALM1,KEGG_2019_Mouse,turquoise
Ubiquinone and other terpenoid-quinone biosynthesis,1/11,0.0536582567508638,0.501100499011177,0,0,20.0909090909091,58.7683184218827,COQ2,KEGG_2019_Mouse,turquoise
Salivary secretion,2/78,0.058168160710821,0.501100499011177,0,0,5.32330827067669,15.1417092906877,ATP1B1;CALM1,KEGG_2019_Mouse,turquoise
Axon guidance,3/180,0.0615800766393562,0.501100499011177,0,0,3.44626943910536,9.60618964872885,EPHA5;GSK3B;TRPC1,KEGG_2019_Mouse,turquoise
ErbB signaling pathway,2/84,0.0662504359060044,0.501100499011177,0,0,4.93230462916874,13.3878197311643,GSK3B;MAP2K4,KEGG_2019_Mouse,turquoise
Rheumatoid arthritis,2/84,0.0662504359060044,0.501100499011177,0,0,4.93230462916874,13.3878197311643,ATP6V0B;ATP6V1B2,KEGG_2019_Mouse,turquoise
Insulin secretion,2/86,0.0690235124413976,0.501100499011177,0,0,4.81438289601555,12.8703286595916,RAB3A;ATP1B1,KEGG_2019_Mouse,turquoise
GnRH signaling pathway,2/90,0.0746819496854828,0.501100499011177,0,0,4.59461966604824,11.9208181587653,MAP2K4;CALM1,KEGG_2019_Mouse,turquoise
Selenocompound metabolism,1/17,0.0817146326715557,0.501100499011177,0,0,12.5530303030303,31.4393429542943,PSTK,KEGG_2019_Mouse,turquoise
Glycerophospholipid metabolism,2/97,0.0849237360045433,0.501100499011177,0,0,4.25456498388829,10.491764264828,GPCPD1;DGKI,KEGG_2019_Mouse,turquoise
Phosphatidylinositol signaling system,2/98,0.0864201908419546,0.501100499011177,0,0,4.21003401360544,10.3084111715959,CALM1;DGKI,KEGG_2019_Mouse,turquoise
Melanogenesis,2/100,0.0894369333512962,0.501100499011177,0,0,4.12369845897543,9.95552171579456,GSK3B;CALM1,KEGG_2019_Mouse,turquoise
Aldosterone synthesis and secretion,2/102,0.0924846891098034,0.501100499011177,0,0,4.04081632653061,9.62002061056518,ATP1B1;CALM1,KEGG_2019_Mouse,turquoise
Kaposi sarcoma-associated herpesvirus infection,3/216,0.0941331217907138,0.501100499011177,0,0,2.85857412516335,6.7549401777521,MAP2K4;GSK3B;CALM1,KEGG_2019_Mouse,turquoise
Pancreatic secretion,2/105,0.0971124998083677,0.501100499011177,0,0,3.92252823459481,9.1468854610462,TRPC1;ATP1B1,KEGG_2019_Mouse,turquoise
Proximal tubule bicarbonate reclamation,1/22,0.104464697819105,0.508628236379676,0,0,9.56180856180856,21.5992275397069,ATP1B1,KEGG_2019_Mouse,turquoise
Human papillomavirus infection,4/360,0.10645707273063,0.508628236379676,0,0,2.2874531835206,5.12392589284857,GSK3B;ATP6V0B;ATP6V1B2;UBE3A,KEGG_2019_Mouse,turquoise
Thyroid hormone signaling pathway,2/115,0.112990010336963,0.520561119052435,0,0,3.57359581000542,7.7920679547705,GSK3B;ATP1B1,KEGG_2019_Mouse,turquoise
Neurotrophin signaling pathway,2/121,0.122818201919793,0.527055059905311,0,0,3.39238552563883,7.11400223667125,GSK3B;CALM1,KEGG_2019_Mouse,turquoise
Collecting duct acid secretion,1/27,0.126656642302827,0.527055059905311,0,0,7.72105672105672,15.9538300108164,ATP6V1B2,KEGG_2019_Mouse,turquoise
Phototransduction,1/27,0.126656642302827,0.527055059905311,0,0,7.72105672105672,15.9538300108164,CALM1,KEGG_2019_Mouse,turquoise
Dopaminergic synapse,2/135,0.146494146719129,0.576032346141224,0,0,3.03314408470155,5.82597157350083,GSK3B;CALM1,KEGG_2019_Mouse,turquoise
SNARE interactions in vesicular transport,1/33,0.152569319997184,0.576032346141224,0,0,6.27146464646465,11.7912078898077,VTI1B,KEGG_2019_Mouse,turquoise
Insulin signaling pathway,2/139,0.1534237633251,0.576032346141224,0,0,2.94398927454193,5.51865948464525,GSK3B;CALM1,KEGG_2019_Mouse,turquoise
Fluid shear stress and atherosclerosis,2/143,0.160416714470738,0.576032346141224,0,0,2.85989289332754,5.23354789527023,MAP2K4;CALM1,KEGG_2019_Mouse,turquoise
Parkinson disease,2/144,0.162174238541576,0.576032346141224,0,0,2.83960908306985,5.16548737879535,COX8A;COX5B,KEGG_2019_Mouse,turquoise
Adrenergic signaling in cardiomyocytes,2/148,0.169239108858938,0.576032346141224,0,0,2.76125244618395,4.90520680248974,ATP1B1;CALM1,KEGG_2019_Mouse,turquoise
Aldosterone-regulated sodium reabsorption,1/38,0.173580657931626,0.576032346141224,0,0,5.42260442260442,9.49559255823113,ATP1B1,KEGG_2019_Mouse,turquoise
mTOR signaling pathway,2/154,0.179932321463797,0.576032346141224,0,0,2.65145005370569,4.54769949538142,GSK3B;ATP6V1B2,KEGG_2019_Mouse,turquoise
Ferroptosis,1/40,0.181840038445641,0.576032346141224,0,0,5.14400414400414,8.76861291991989,FTH1,KEGG_2019_Mouse,turquoise
Carbohydrate digestion and absorption,1/43,0.19407611900782,0.576032346141224,0,0,4.77585377585378,7.83003533696715,ATP1B1,KEGG_2019_Mouse,turquoise
Hedgehog signaling pathway,1/44,0.1981144149655,0.576032346141224,0,0,4.6645525017618,7.55149331126355,GSK3B,KEGG_2019_Mouse,turquoise
Tight junction,2/167,0.203427034299401,0.576032346141224,0,0,2.44094001236858,3.88706977769903,HSPA4;WASL,KEGG_2019_Mouse,turquoise
Influenza A,2/168,0.20524959092647,0.576032346141224,0,0,2.42611261372019,3.84181852553833,MAP2K4;GSK3B,KEGG_2019_Mouse,turquoise
Ether lipid metabolism,1/47,0.210109494168341,0.576032346141224,0,0,4.3596837944664,6.80165814675797,PAFAH1B1,KEGG_2019_Mouse,turquoise
cGMP-PKG signaling pathway,2/172,0.212557721644281,0.576032346141224,0,0,2.36854741896759,3.66779443778241,ATP1B1;CALM1,KEGG_2019_Mouse,turquoise
Tuberculosis,2/178,0.223566841614148,0.576032346141224,0,0,2.28710575139147,3.42618697401597,ATP6V0B;CALM1,KEGG_2019_Mouse,turquoise
Phagosome,2/180,0.227247144429194,0.576032346141224,0,0,2.26117862875487,3.35042706699839,ATP6V0B;ATP6V1B2,KEGG_2019_Mouse,turquoise
Endocrine and other factor-regulated calcium reabsorption,1/55,0.241234861655302,0.576032346141224,0,0,3.71230826786382,5.27884403782842,ATP1B1,KEGG_2019_Mouse,turquoise
Huntington disease,2/192,0.249408486067724,0.576032346141224,0,0,2.11707841031149,2.93990892306422,COX8A;COX5B,KEGG_2019_Mouse,turquoise
Endometrial cancer,1/58,0.252591147960672,0.576032346141224,0,0,3.5163919900762,4.83849599837867,GSK3B,KEGG_2019_Mouse,turquoise
Lysine degradation,1/59,0.256339055642632,0.576032346141224,0,0,3.45559038662487,4.70393718537215,NSD3,KEGG_2019_Mouse,turquoise
Chemokine signaling pathway,2/197,0.258668230043533,0.576032346141224,0,0,2.06227106227106,2.78862149806572,GSK3B;WASL,KEGG_2019_Mouse,turquoise
Glycerolipid metabolism,1/61,0.263779141308675,0.576032346141224,0,0,3.34006734006734,4.45111773409346,DGKI,KEGG_2019_Mouse,turquoise
Basal cell carcinoma,1/63,0.271145528260931,0.576032346141224,0,0,3.23199739328772,4.21807849737542,GSK3B,KEGG_2019_Mouse,turquoise
Rap1 signaling pathway,2/209,0.280904713771957,0.576032346141224,0,0,1.94153603470374,2.46524550660258,CALM1;PFN2,KEGG_2019_Mouse,turquoise
Aminoacyl-tRNA biosynthesis,1/66,0.282058502576368,0.576032346141224,0,0,3.08236208236208,3.90116313048372,PSTK,KEGG_2019_Mouse,turquoise
cAMP signaling pathway,2/211,0.284608511779544,0.576032346141224,0,0,1.92276144907724,2.41622026619919,ATP1B1;CALM1,KEGG_2019_Mouse,turquoise
Long-term potentiation,1/67,0.285660089808726,0.576032346141224,0,0,3.03550658096113,3.80334608196671,CALM1,KEGG_2019_Mouse,turquoise
Amphetamine addiction,1/68,0.289243789255229,0.576032346141224,0,0,2.99004975124378,3.70911301693322,CALM1,KEGG_2019_Mouse,turquoise
Fc epsilon RI signaling pathway,1/68,0.289243789255229,0.576032346141224,0,0,2.99004975124378,3.70911301693322,MAP2K4,KEGG_2019_Mouse,turquoise
Regulation of actin cytoskeleton,2/217,0.295709072188337,0.576032346141224,0,0,1.86853345989559,2.27658225012256,WASL;PFN2,KEGG_2019_Mouse,turquoise
Adherens junction,1/72,0.303401461859655,0.576032346141224,0,0,2.82102717313985,3.36463457832852,WASL,KEGG_2019_Mouse,turquoise
B cell receptor signaling pathway,1/72,0.303401461859655,0.576032346141224,0,0,2.82102717313985,3.36463457832852,GSK3B,KEGG_2019_Mouse,turquoise
Bile secretion,1/72,0.303401461859655,0.576032346141224,0,0,2.82102717313985,3.36463457832852,ATP1B1,KEGG_2019_Mouse,turquoise
Prolactin signaling pathway,1/72,0.303401461859655,0.576032346141224,0,0,2.82102717313985,3.36463457832852,GSK3B,KEGG_2019_Mouse,turquoise
Thyroid hormone synthesis,1/73,0.306897033111884,0.576032346141224,0,0,2.78170594837262,3.28587063696556,ATP1B1,KEGG_2019_Mouse,turquoise
Bacterial invasion of epithelial cells,1/74,0.310375237892897,0.576032346141224,0,0,2.74346201743462,3.20977722405069,WASL,KEGG_2019_Mouse,turquoise
Glioma,1/75,0.313836161648445,0.576032346141224,0,0,2.70625170625171,3.13623236372496,CALM1,KEGG_2019_Mouse,turquoise
Pertussis,1/76,0.317279889350664,0.576032346141224,0,0,2.67003367003367,3.0651211233087,CALM1,KEGG_2019_Mouse,turquoise
Renin secretion,1/76,0.317279889350664,0.576032346141224,0,0,2.67003367003367,3.0651211233087,CALM1,KEGG_2019_Mouse,turquoise
Thermogenesis,2/231,0.321506425753241,0.576032346141224,0,0,1.75305231262811,1.98925463460844,COX8A;COX5B,KEGG_2019_Mouse,turquoise
Fc gamma R-mediated phagocytosis,1/87,0.354049852499014,0.599162258972818,0,0,2.3272257458304,2.41639933353241,WASL,KEGG_2019_Mouse,turquoise
Colorectal cancer,1/88,0.357293708483398,0.599162258972818,0,0,2.30035992104958,2.36752381170365,GSK3B,KEGG_2019_Mouse,turquoise
Antigen processing and presentation,1/90,0.363733115678147,0.599162258972818,0,0,2.24843945068664,2.27392523969427,HSPA4,KEGG_2019_Mouse,turquoise
Protein digestion and absorption,1/90,0.363733115678147,0.599162258972818,0,0,2.24843945068664,2.27392523969427,ATP1B1,KEGG_2019_Mouse,turquoise
Human cytomegalovirus infection,2/255,0.365155885449267,0.599162258972818,0,0,1.58481890780027,1.59659559116084,GSK3B;CALM1,KEGG_2019_Mouse,turquoise
TGF-beta signaling pathway,1/91,0.366928825262423,0.599162258972818,0,0,2.22334455667789,2.22909720803597,ZFYVE9,KEGG_2019_Mouse,turquoise
IL-17 signaling pathway,1/91,0.366928825262423,0.599162258972818,0,0,2.22334455667789,2.22909720803597,GSK3B,KEGG_2019_Mouse,turquoise
Prostate cancer,1/97,0.385772094842852,0.606089908609778,0,0,2.08375420875421,1.98479362024731,GSK3B,KEGG_2019_Mouse,turquoise
Toll-like receptor signaling pathway,1/99,0.391928946523868,0.606089908609778,0,0,2.0410224695939,1.91177413897195,MAP2K4,KEGG_2019_Mouse,turquoise
Circadian entrainment,1/99,0.391928946523868,0.606089908609778,0,0,2.0410224695939,1.91177413897195,CALM1,KEGG_2019_Mouse,turquoise
T cell receptor signaling pathway,1/101,0.398024694482133,0.606089908609778,0,0,2.0,1.84248245836996,GSK3B,KEGG_2019_Mouse,turquoise
Glucagon signaling pathway,1/102,0.401049842395342,0.606089908609778,0,0,1.98009800980098,1.80915528558786,CALM1,KEGG_2019_Mouse,turquoise
Longevity regulating pathway,1/102,0.401049842395342,0.606089908609778,0,0,1.98009800980098,1.80915528558786,RB1CC1,KEGG_2019_Mouse,turquoise
Chagas disease (American trypanosomiasis),1/103,0.404059939073185,0.606089908609778,0,0,1.9605862547039,1.77666767339805,MAP2K4,KEGG_2019_Mouse,turquoise
TNF signaling pathway,1/110,0.424715362613925,0.622594111104503,0,0,1.83402835696414,1.57054463447437,MAP2K4,KEGG_2019_Mouse,turquoise
Insulin resistance,1/110,0.424715362613925,0.622594111104503,0,0,1.83402835696414,1.57054463447437,GSK3B,KEGG_2019_Mouse,turquoise
C-type lectin receptor signaling pathway,1/112,0.43048561638067,0.623962297900073,0,0,1.8008008008008,1.51778940882089,CALM1,KEGG_2019_Mouse,turquoise
Glutamatergic synapse,1/114,0.436198565833718,0.625217944361663,0,0,1.76874944131581,1.46745661650072,TRPC1,KEGG_2019_Mouse,turquoise
Oocyte meiosis,1/116,0.441854774426629,0.626365559352035,0,0,1.73781291172596,1.41940043016639,CALM1,KEGG_2019_Mouse,turquoise
Cell cycle,1/123,0.461212676190375,0.636948548762369,0,0,1.63752276867031,1.26727232996582,GSK3B,KEGG_2019_Mouse,turquoise
Lysosome,1/124,0.463923277206856,0.636948548762369,0,0,1.62412745339575,1.2473885010387,ATP6V0B,KEGG_2019_Mouse,turquoise
Inflammatory mediator regulation of TRP channels,1/127,0.471974339207137,0.636948548762369,0,0,1.58521725188392,1.19022971699885,CALM1,KEGG_2019_Mouse,turquoise
Autophagy,1/130,0.479905677193982,0.636948548762369,0,0,1.54811682718659,1.13657427447839,RB1CC1,KEGG_2019_Mouse,turquoise
Relaxin signaling pathway,1/131,0.482523156606063,0.636948548762369,0,0,1.53613053613054,1.11941882389327,MAP2K4,KEGG_2019_Mouse,turquoise
Serotonergic synapse,1/132,0.485127594032975,0.636948548762369,0,0,1.52432724188449,1.1026119616962,TRPC1,KEGG_2019_Mouse,turquoise
Estrogen signaling pathway,1/134,0.490297600070642,0.636948548762369,0,0,1.50125313283208,1.07000724904239,CALM1,KEGG_2019_Mouse,turquoise
Signaling pathways regulating pluripotency of stem cells,1/137,0.497956392525298,0.636948548762369,0,0,1.46791443850267,1.02349273069514,GSK3B,KEGG_2019_Mouse,turquoise
Apelin signaling pathway,1/138,0.500483918197201,0.636948548762369,0,0,1.45712600457126,1.00859320422095,CALM1,KEGG_2019_Mouse,turquoise
Ubiquitin mediated proteolysis,1/138,0.500483918197201,0.636948548762369,0,0,1.45712600457126,1.00859320422095,UBE3A,KEGG_2019_Mouse,turquoise
Vascular smooth muscle contraction,1/140,0.505501237241334,0.636948548762369,0,0,1.43601482450403,0.979656196045578,CALM1,KEGG_2019_Mouse,turquoise
Measles,1/144,0.515386675547343,0.636948548762369,0,0,1.39556403192767,0.925032639771104,GSK3B,KEGG_2019_Mouse,turquoise
Breast cancer,1/147,0.522672127159014,0.636948548762369,0,0,1.36668050366681,0.886703567337748,GSK3B,KEGG_2019_Mouse,turquoise
Phospholipase D signaling pathway,1/149,0.527468747150282,0.636948548762369,0,0,1.34807534807535,0.862317510620557,DGKI,KEGG_2019_Mouse,turquoise
Gastric cancer,1/150,0.529849131261317,0.636948548762369,0,0,1.33896007050369,0.850457856372934,GSK3B,KEGG_2019_Mouse,turquoise
PI3K-Akt signaling pathway,2/357,0.535383524596221,0.636948548762369,0,0,1.12359873526876,0.701992939715793,GSK3B;PKN2,KEGG_2019_Mouse,turquoise
Oxytocin signaling pathway,1/154,0.539252532966754,0.636948548762369,0,0,1.30369049976893,0.805121832204194,CALM1,KEGG_2019_Mouse,turquoise
Cushing syndrome,1/159,0.550745324592532,0.636948548762369,0,0,1.26211481907684,0.75282975911799,GSK3B,KEGG_2019_Mouse,turquoise
Hippo signaling pathway,1/159,0.550745324592532,0.636948548762369,0,0,1.26211481907684,0.75282975911799,GSK3B,KEGG_2019_Mouse,turquoise
Wnt signaling pathway,1/160,0.553009592723917,0.636948548762369,0,0,1.25411346166063,0.742911645774827,GSK3B,KEGG_2019_Mouse,turquoise
Hepatitis C,1/160,0.553009592723917,0.636948548762369,0,0,1.25411346166063,0.742911645774827,GSK3B,KEGG_2019_Mouse,turquoise
Hepatitis B,1/163,0.559734829149778,0.638989318232932,0,0,1.23070208255393,0.714166728910465,MAP2K4,KEGG_2019_Mouse,turquoise
RNA transport,1/167,0.568546217907677,0.641867284945145,0,0,1.20080321285141,0.678060757672765,EIF1,KEGG_2019_Mouse,turquoise
Ribosome,1/170,0.575039975380935,0.641867284945145,0,0,1.17930787161556,0.652529581961561,RPS2,KEGG_2019_Mouse,turquoise
Hepatocellular carcinoma,1/171,0.577182984911913,0.641867284945145,0,0,1.17231134878194,0.644297547374328,GSK3B,KEGG_2019_Mouse,turquoise
Necroptosis,1/176,0.587738595192884,0.648019476751129,0,0,1.13852813852814,0.60509696073503,FTH1,KEGG_2019_Mouse,turquoise
Cellular senescence,1/185,0.606085393723219,0.662584879578773,0,0,1.08234519104084,0.541967458037162,CALM1,KEGG_2019_Mouse,turquoise
Calcium signaling pathway,1/189,0.613977814396427,0.665572588715455,0,0,1.05910165484634,0.516626063848475,CALM1,KEGG_2019_Mouse,turquoise
Alcoholism,1/199,0.633030530285215,0.67488378848589,0,0,1.00510152025304,0.459569228815331,CALM1,KEGG_2019_Mouse,turquoise
Focal adhesion,1/199,0.633030530285215,0.67488378848589,0,0,1.00510152025304,0.459569228815331,GSK3B,KEGG_2019_Mouse,turquoise
Viral carcinogenesis,1/229,0.684778279205045,0.718182097702852,0,0,0.871522239943293,0.330010762244593,UBE3A,KEGG_2019_Mouse,turquoise
Epstein-Barr virus infection,1/229,0.684778279205045,0.718182097702852,0,0,0.871522239943293,0.330010762244593,MAP2K4,KEGG_2019_Mouse,turquoise
Ras signaling pathway,1/233,0.691107962443606,0.718975218993752,0,0,0.85632183908046,0.316376004340495,CALM1,KEGG_2019_Mouse,turquoise
Human immunodeficiency virus 1 infection,1/238,0.698843373301633,0.721206361247286,0,0,0.83804287601756,0.300294759320438,CALM1,KEGG_2019_Mouse,turquoise
Human T-cell leukemia virus 1 infection,1/245,0.709351740244625,0.726241067393306,0,0,0.81371087928465,0.279431381953944,MAP2K4,KEGG_2019_Mouse,turquoise
Pathways in cancer,2/535,0.751707086711428,0.763544993588774,0,0,0.741547650955316,0.211644034819821,GSK3B;CALM1,KEGG_2019_Mouse,turquoise
MAPK signaling pathway,1/294,0.773409712864383,0.779451976246136,0,0,0.675940290274761,0.173680384477407,MAP2K4,KEGG_2019_Mouse,turquoise
Olfactory transduction,1/1133,0.997108021558509,0.997108021558509,0,0,0.16746975050862,0.0004850205811354,CALM1,KEGG_2019_Mouse,turquoise
PPAR signaling pathway,3/85,0.008907727513708,0.312101127633592,0,0,7.47472969575057,35.2869739274349,UBC;SCD2;ACSL3,KEGG_2019_Mouse,blue
Morphine addiction,3/92,0.0110454740818408,0.312101127633592,0,0,6.88439708096838,31.0192655790006,GNAO1;GABBR1;PDE4B,KEGG_2019_Mouse,blue
Alzheimer disease,4/175,0.0115860323949771,0.312101127633592,0,0,4.807261208577,21.4305541904363,APP;APOE;MAPT;RTN4,KEGG_2019_Mouse,blue
Phagosome,4/180,0.012738821536065,0.312101127633592,0,0,4.66950757575758,20.373533799992,TUBA1A;LAMP1;TUBB4A;ACTB,KEGG_2019_Mouse,blue
Phosphonate and phosphinate metabolism,1/6,0.0296309633944118,0.473099994778487,0,0,40.1919191919192,141.432767389918,PCYT2,KEGG_2019_Mouse,blue
Endocrine and other factor-regulated calcium reabsorption,2/55,0.030955668405524,0.473099994778487,0,0,7.64227955333077,26.5584434034501,DNM3;AP2A1,KEGG_2019_Mouse,blue
Apoptosis,3/141,0.0337928567698919,0.473099994778487,0,0,4.42895562528014,15.0031130324376,TUBA1A;SEPT4;ACTB,KEGG_2019_Mouse,blue
Hippo signaling pathway,3/159,0.0455880793261004,0.483164587089784,0,0,3.91435368754956,12.0879509101259,PAK1;YWHAQ;ACTB,KEGG_2019_Mouse,blue
Bacterial invasion of epithelial cells,2/74,0.0529880944930012,0.483164587089784,0,0,5.62018140589569,16.5103396024628,DNM3;ACTB,KEGG_2019_Mouse,blue
Cell adhesion molecules (CAMs),3/170,0.0536732252855458,0.483164587089784,0,0,3.6544848447435,10.6887871072113,NFASC;CNTN2;NCAM1,KEGG_2019_Mouse,blue
Synaptic vesicle cycle,2/77,0.0568570608364097,0.483164587089784,0,0,5.39455782312925,15.4673563823572,DNM3;AP2A1,KEGG_2019_Mouse,blue
Peroxisome,2/84,0.0662504359060044,0.483164587089784,0,0,4.93230462916874,13.3878197311643,PEX5L;ACSL3,KEGG_2019_Mouse,blue
Fatty acid biosynthesis,1/14,0.0677909321684321,0.483164587089784,0,0,15.4522144522145,41.5869594433684,ACSL3,KEGG_2019_Mouse,blue
Gap junction,2/86,0.0690235124413976,0.483164587089784,0,0,4.81438289601555,12.8703286595916,TUBA1A;TUBB4A,KEGG_2019_Mouse,blue
GABAergic synapse,2/90,0.0746819496854828,0.485926634336948,0,0,4.59461966604824,11.9208181587653,GNAO1;GABBR1,KEGG_2019_Mouse,blue
Proteoglycans in cancer,3/203,0.0816743571184012,0.485926634336948,0,0,3.04639175257732,7.63125762325125,PAK1;ANK3;ACTB,KEGG_2019_Mouse,blue
Rap1 signaling pathway,3/209,0.0873302976244391,0.485926634336948,0,0,2.95676108497648,7.2087544984596,GNAO1;MAGI2;ACTB,KEGG_2019_Mouse,blue
cAMP signaling pathway,3/211,0.0892518307965823,0.485926634336948,0,0,2.92803330689929,7.0749873945873,PAK1;GABBR1;PDE4B,KEGG_2019_Mouse,blue
Lysosome,2/124,0.127808625420924,0.556755503851525,0,0,3.3084643693543,6.80624319809133,ABCA2;LAMP1,KEGG_2019_Mouse,blue
Serotonergic synapse,2/132,0.141341709574619,0.556755503851525,0,0,3.10361067503925,6.07244658574773,GNAO1;APP,KEGG_2019_Mouse,blue
Glyoxylate and dicarboxylate metabolism,1/31,0.144017471501311,0.556755503851525,0,0,6.69023569023569,12.9644769200402,ACSS2,KEGG_2019_Mouse,blue
Propanoate metabolism,1/31,0.144017471501311,0.556755503851525,0,0,6.69023569023569,12.9644769200402,ACSS2,KEGG_2019_Mouse,blue
Estrogen signaling pathway,2/134,0.144772261600204,0.556755503851525,0,0,3.05627705627706,5.90654080920543,GNAO1;GABBR1,KEGG_2019_Mouse,blue
Biosynthesis of unsaturated fatty acids,1/32,0.148304021933978,0.556755503851525,0,0,6.47409579667644,12.3557529781019,SCD2,KEGG_2019_Mouse,blue
Pentose phosphate pathway,1/32,0.148304021933978,0.556755503851525,0,0,6.47409579667644,12.3557529781019,TKT,KEGG_2019_Mouse,blue
Endocytosis,3/269,0.151922507131825,0.556755503851525,0,0,2.28284629098519,4.30176064519131,DNM3;AP2A1;EPN2,KEGG_2019_Mouse,blue
Prion diseases,1/34,0.156813470025957,0.556755503851525,0,0,6.08111417202326,11.2664696999635,NCAM1,KEGG_2019_Mouse,blue
Pyruvate metabolism,1/38,0.173580657931626,0.556755503851525,0,0,5.42260442260442,9.49559255823113,ACSS2,KEGG_2019_Mouse,blue
Oxytocin signaling pathway,2/154,0.179932321463797,0.556755503851525,0,0,2.65145005370569,4.54769949538142,GNAO1;ACTB,KEGG_2019_Mouse,blue
Ferroptosis,1/40,0.181840038445641,0.556755503851525,0,0,5.14400414400414,8.76861291991989,ACSL3,KEGG_2019_Mouse,blue
Hepatitis C,2/160,0.190726471409696,0.556755503851525,0,0,2.54998708344097,4.22511175710114,YWHAQ;CD81,KEGG_2019_Mouse,blue
Tight junction,2/167,0.203427034299401,0.556755503851525,0,0,2.44094001236858,3.88706977769903,TUBA1A;ACTB,KEGG_2019_Mouse,blue
Ether lipid metabolism,1/47,0.210109494168341,0.556755503851525,0,0,4.3596837944664,6.80165814675797,ENPP2,KEGG_2019_Mouse,blue
ABC transporters,1/48,0.214068244088033,0.556755503851525,0,0,4.26670964968837,6.57696403663591,ABCA2,KEGG_2019_Mouse,blue
Cholesterol metabolism,1/49,0.21800735103248,0.556755503851525,0,0,4.17760942760943,6.36344537186664,APOE,KEGG_2019_Mouse,blue
Malaria,1/49,0.21800735103248,0.556755503851525,0,0,4.17760942760943,6.36344537186664,CD81,KEGG_2019_Mouse,blue
Arginine and proline metabolism,1/50,0.221926911560385,0.556755503851525,0,0,4.09214594928881,6.16034588762116,CKB,KEGG_2019_Mouse,blue
Cysteine and methionine metabolism,1/50,0.221926911560385,0.556755503851525,0,0,4.09214594928881,6.16034588762116,MAT2A,KEGG_2019_Mouse,blue
Fatty acid degradation,1/50,0.221926911560385,0.556755503851525,0,0,4.09214594928881,6.16034588762116,ACSL3,KEGG_2019_Mouse,blue
Axon guidance,2/180,0.227247144429194,0.556755503851525,0,0,2.26117862875487,3.35042706699839,PAK1;UNC5C,KEGG_2019_Mouse,blue
Focal adhesion,2/199,0.262374132122319,0.592575275766255,0,0,2.04112711074277,2.73099502551452,PAK1;ACTB,KEGG_2019_Mouse,blue
Long-term depression,1/61,0.263779141308675,0.592575275766255,0,0,3.34006734006734,4.45111773409346,GNAO1,KEGG_2019_Mouse,blue
Glycolysis / Gluconeogenesis,1/67,0.285660089808726,0.592575275766255,0,0,3.03550658096113,3.80334608196671,ACSS2,KEGG_2019_Mouse,blue
Renal cell carcinoma,1/68,0.289243789255229,0.592575275766255,0,0,2.99004975124378,3.70911301693322,PAK1,KEGG_2019_Mouse,blue
Regulation of actin cytoskeleton,2/217,0.295709072188337,0.592575275766255,0,0,1.86853345989559,2.27658225012256,PAK1;ACTB,KEGG_2019_Mouse,blue
Adipocytokine signaling pathway,1/71,0.299888438313403,0.592575275766255,0,0,2.86147186147186,3.44619860155019,ACSL3,KEGG_2019_Mouse,blue
Adherens junction,1/72,0.303401461859655,0.592575275766255,0,0,2.82102717313985,3.36463457832852,ACTB,KEGG_2019_Mouse,blue
Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.303401461859655,0.592575275766255,0,0,2.82102717313985,3.36463457832852,ACTB,KEGG_2019_Mouse,blue
B cell receptor signaling pathway,1/72,0.303401461859655,0.592575275766255,0,0,2.82102717313985,3.36463457832852,CD81,KEGG_2019_Mouse,blue
Gastric acid secretion,1/74,0.310375237892897,0.592575275766255,0,0,2.74346201743462,3.20977722405069,ACTB,KEGG_2019_Mouse,blue
Thermogenesis,2/231,0.321506425753241,0.592575275766255,0,0,1.75305231262811,1.98925463460844,ACSL3;ACTB,KEGG_2019_Mouse,blue
Salmonella infection,1/78,0.324116094429913,0.592575275766255,0,0,2.60041978223796,2.92977207832515,ACTB,KEGG_2019_Mouse,blue
Human immunodeficiency virus 1 infection,2/238,0.334326152614819,0.592575275766255,0,0,1.70044967139398,1.86307771517288,GNAO1;PAK1,KEGG_2019_Mouse,blue
ErbB signaling pathway,1/84,0.344220716526821,0.592575275766255,0,0,2.41170743580382,2.57201895784243,PAK1,KEGG_2019_Mouse,blue
Hypertrophic cardiomyopathy (HCM),1/86,0.350789788685405,0.592575275766255,0,0,2.35472370766488,2.46673350535558,ACTB,KEGG_2019_Mouse,blue
Viral myocarditis,1/87,0.354049852499014,0.592575275766255,0,0,2.3272257458304,2.41639933353241,ACTB,KEGG_2019_Mouse,blue
Fc gamma R-mediated phagocytosis,1/87,0.354049852499014,0.592575275766255,0,0,2.3272257458304,2.41639933353241,PAK1,KEGG_2019_Mouse,blue
Taste transduction,1/88,0.357293708483398,0.592575275766255,0,0,2.30035992104958,2.36752381170365,GABBR1,KEGG_2019_Mouse,blue
Dilated cardiomyopathy (DCM),1/90,0.363733115678147,0.592575275766255,0,0,2.24843945068664,2.27392523969427,ACTB,KEGG_2019_Mouse,blue
Glycerophospholipid metabolism,1/97,0.385772094842852,0.592575275766255,0,0,2.08375420875421,1.98479362024731,PCYT2,KEGG_2019_Mouse,blue
Circadian entrainment,1/99,0.391928946523868,0.592575275766255,0,0,2.0410224695939,1.91177413897195,GNAO1,KEGG_2019_Mouse,blue
Melanogenesis,1/100,0.394984420817951,0.592575275766255,0,0,2.02030405060708,1.87667852610055,GNAO1,KEGG_2019_Mouse,blue
T cell receptor signaling pathway,1/101,0.398024694482133,0.592575275766255,0,0,2.0,1.84248245836996,PAK1,KEGG_2019_Mouse,blue
Chagas disease (American trypanosomiasis),1/103,0.404059939073185,0.592575275766255,0,0,1.9605862547039,1.77666767339805,GNAO1,KEGG_2019_Mouse,blue
"Parathyroid hormone synthesis, secretion and action",1/107,0.41595129052059,0.592575275766255,0,0,1.88622069754145,1.65456849319568,PDE4B,KEGG_2019_Mouse,blue
Toxoplasmosis,1/108,0.41888723576301,0.592575275766255,0,0,1.86849806475975,1.62588017253325,GNAO1,KEGG_2019_Mouse,blue
C-type lectin receptor signaling pathway,1/112,0.43048561638067,0.592575275766255,0,0,1.8008008008008,1.51778940882089,PAK1,KEGG_2019_Mouse,blue
Cholinergic synapse,1/113,0.433349218837219,0.592575275766255,0,0,1.78463203463203,1.4923295915181,GNAO1,KEGG_2019_Mouse,blue
MAPK signaling pathway,2/294,0.433647407322141,0.592575275766255,0,0,1.37042214145932,1.14501990493626,PAK1;MAPT,KEGG_2019_Mouse,blue
Glutamatergic synapse,1/114,0.436198565833718,0.592575275766255,0,0,1.76874944131581,1.46745661650072,GNAO1,KEGG_2019_Mouse,blue
Thyroid hormone signaling pathway,1/115,0.439033727758999,0.592575275766255,0,0,1.7531454899876,1.44315262186649,ACTB,KEGG_2019_Mouse,blue
Leukocyte transendothelial migration,1/115,0.439033727758999,0.592575275766255,0,0,1.7531454899876,1.44315262186649,ACTB,KEGG_2019_Mouse,blue
Oocyte meiosis,1/116,0.441854774426629,0.592575275766255,0,0,1.73781291172596,1.41940043016639,YWHAQ,KEGG_2019_Mouse,blue
Natural killer cell mediated cytotoxicity,1/118,0.447454800068397,0.592575275766255,0,0,1.70793404126737,1.37348597340122,PAK1,KEGG_2019_Mouse,blue
Cell cycle,1/123,0.461212676190375,0.59729605386708,0,0,1.63752276867031,1.26727232996582,YWHAQ,KEGG_2019_Mouse,blue
Platelet activation,1/125,0.46662037707619,0.59729605386708,0,0,1.61094819159335,1.22792793965158,ACTB,KEGG_2019_Mouse,blue
AMPK signaling pathway,1/126,0.469304042324134,0.59729605386708,0,0,1.5979797979798,1.20887881651748,SCD2,KEGG_2019_Mouse,blue
Autophagy,1/130,0.479905677193982,0.598573029713851,0,0,1.54811682718659,1.13657427447839,LAMP1,KEGG_2019_Mouse,blue
Relaxin signaling pathway,1/131,0.482523156606063,0.598573029713851,0,0,1.53613053613054,1.11941882389327,GNAO1,KEGG_2019_Mouse,blue
Dopaminergic synapse,1/135,0.492863296366116,0.599392446991292,0,0,1.48997437057139,1.05419178131578,GNAO1,KEGG_2019_Mouse,blue
Purine metabolism,1/136,0.49541620618668,0.599392446991292,0,0,1.47886270108492,1.03868964279636,PDE4B,KEGG_2019_Mouse,blue
Fluid shear stress and atherosclerosis,1/143,0.512933812590885,0.613018458950082,0,0,1.40546308151942,0.938299046849509,ACTB,KEGG_2019_Mouse,blue
Phospholipase D signaling pathway,1/149,0.527468747150282,0.617265710710937,0,0,1.34807534807535,0.862317510620557,DNM3,KEGG_2019_Mouse,blue
Retrograde endocannabinoid signaling,1/150,0.529849131261317,0.617265710710937,0,0,1.33896007050369,0.850457856372934,GNAO1,KEGG_2019_Mouse,blue
PI3K-Akt signaling pathway,2/357,0.535383524596221,0.617265710710937,0,0,1.12359873526876,0.701992939715793,YWHAQ;MAGI2,KEGG_2019_Mouse,blue
Wnt signaling pathway,1/160,0.553009592723917,0.630173721941208,0,0,1.25411346166063,0.742911645774827,DAAM1,KEGG_2019_Mouse,blue
Hepatitis B,1/163,0.559734829149778,0.630505899502049,0,0,1.23070208255393,0.714166728910465,YWHAQ,KEGG_2019_Mouse,blue
Influenza A,1/168,0.570721645453221,0.635549803610871,0,0,1.19355228936067,0.669408186906394,ACTB,KEGG_2019_Mouse,blue
Hepatocellular carcinoma,1/171,0.577182984911913,0.635549803610871,0,0,1.17231134878194,0.644297547374328,ACTB,KEGG_2019_Mouse,blue
Tuberculosis,1/178,0.591887411720754,0.644499626095933,0,0,1.12554927809165,0.590281763493508,LAMP1,KEGG_2019_Mouse,blue
Huntington disease,1/192,0.619794203522166,0.667064429762914,0,0,1.04230789571104,0.498606520241977,AP2A1,KEGG_2019_Mouse,blue
Chemokine signaling pathway,1/197,0.62929598455177,0.667064429762914,0,0,1.01546072974644,0.470314261452597,PAK1,KEGG_2019_Mouse,blue
Alcoholism,1/199,0.633030530285215,0.667064429762914,0,0,1.00510152025304,0.459569228815331,GNAO1,KEGG_2019_Mouse,blue
Viral carcinogenesis,1/229,0.684778279205045,0.71293242441551,0,0,0.871522239943293,0.330010762244593,YWHAQ,KEGG_2019_Mouse,blue
Ras signaling pathway,1/233,0.691107962443606,0.71293242441551,0,0,0.85632183908046,0.316376004340495,PAK1,KEGG_2019_Mouse,blue
Human cytomegalovirus infection,1/255,0.723736859618685,0.738814710860741,0,0,0.781277340332458,0.252608375993645,GNAO1,KEGG_2019_Mouse,blue
MicroRNAs in cancer,1/281,0.757922669215417,0.765736304980524,0,0,0.707792207792208,0.196181539398202,ZEB2,KEGG_2019_Mouse,blue
Neuroactive ligand-receptor interaction,1/348,0.827904633146956,0.827904633146956,0,0,0.569178819899281,0.107493580032069,GABBR1,KEGG_2019_Mouse,blue
Neuroactive ligand-receptor interaction,7/348,7.13005223958929e-05,0.0033511245526069,0,0,7.73742386645612,73.8816189491813,GABRA5;HTR1F;GRM8;GRIK3;ADORA1;RXFP1;SSTR4,KEGG_2019_Mouse,magenta
Protein digestion and absorption,4/90,0.0001444327275068,0.003394169096411,0,0,16.7906976744186,148.475047124505,COL5A1;COL12A1;COL6A1;SLC8A1,KEGG_2019_Mouse,magenta
Glycosphingolipid biosynthesis,2/45,0.0078073465528601,0.122315095994808,0,0,16.2366381068951,78.7913733690116,B3GALT2;ST3GAL1,KEGG_2019_Mouse,magenta
Glycosaminoglycan biosynthesis,2/53,0.010704648823228,0.125779623672929,0,0,13.6842105263158,62.0863190645338,HS3ST5;ST3GAL1,KEGG_2019_Mouse,magenta
Axon guidance,3/180,0.0161214152283294,0.151541303146297,0,0,5.9818401937046,24.6906839755316,NRP1;SLIT1;SEMA3E,KEGG_2019_Mouse,magenta
Taste transduction,2/88,0.027847676669017,0.202941900305435,0,0,8.10077519379845,29.0089224601859,GABRA5;HTR1F,KEGG_2019_Mouse,magenta
Morphine addiction,2/92,0.0302253894071925,0.202941900305435,0,0,7.73918128654971,27.0799602737577,GABRA5;ADORA1,KEGG_2019_Mouse,magenta
Circadian entrainment,2/99,0.0345726811447628,0.203114501725482,0,0,7.17815156447821,24.152265347098,NOS1AP;RYR3,KEGG_2019_Mouse,magenta
Glutamatergic synapse,2/114,0.0446408219898234,0.233124292613522,0,0,6.21209273182957,19.3140581851406,GRM8;GRIK3,KEGG_2019_Mouse,magenta
Serotonergic synapse,2/132,0.0579561191688583,0.267756583849795,0,0,5.34709851551957,15.2289061680894,HTR1F;KCNN2,KEGG_2019_Mouse,magenta
Apelin signaling pathway,2/138,0.0626664345180372,0.267756583849795,0,0,5.10964912280702,14.1533668656379,RYR3;SLC8A1,KEGG_2019_Mouse,magenta
Mucin type O-glycan biosynthesis,1/28,0.0794442623905929,0.311156694363156,0,0,12.7164750957854,32.2070114548084,ST3GAL1,KEGG_2019_Mouse,magenta
cGMP-PKG signaling pathway,2/172,0.0915749359153218,0.327711136358926,0,0,4.08070175438596,9.75531610650148,ADORA1;SLC8A1,KEGG_2019_Mouse,magenta
Transcriptional misregulation in cancer,2/183,0.101630749394003,0.327711136358926,0,0,3.83057090239411,8.7582523154187,BCL11B;PBX1,KEGG_2019_Mouse,magenta
Calcium signaling pathway,2/189,0.107240613730395,0.327711136358926,0,0,3.70653907496013,8.27551656134492,RYR3;SLC8A1,KEGG_2019_Mouse,magenta
Nicotine addiction,1/40,0.111561237909421,0.327711136358926,0,0,8.79840848806366,19.2965077806476,GABRA5,KEGG_2019_Mouse,magenta
Mineral absorption,1/44,0.12202010623715,0.335474490426402,0,0,7.97834803528468,16.7830091294943,SLC8A1,KEGG_2019_Mouse,magenta
cAMP signaling pathway,2/211,0.128479592078196,0.335474490426402,0,0,3.31268362293293,6.79757777903497,HTR1F;ADORA1,KEGG_2019_Mouse,magenta
Endocrine and other factor-regulated calcium reabsorption,1/55,0.150161909141577,0.343589546477276,0,0,6.34961685823755,12.039134994316,SLC8A1,KEGG_2019_Mouse,magenta
Regulation of lipolysis in adipocytes,1/56,0.152675841124444,0.343589546477276,0,0,6.23385579937304,11.7161472876704,ADORA1,KEGG_2019_Mouse,magenta
Cortisol synthesis and secretion,1/69,0.184699216707237,0.343589546477276,0,0,5.03879310344828,8.51065574827833,PBX1,KEGG_2019_Mouse,magenta
p53 signaling pathway,1/71,0.189519113686836,0.343589546477276,0,0,4.89433497536946,8.140577999806,RPRM,KEGG_2019_Mouse,magenta
Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.19191854685501,0.343589546477276,0,0,4.8251578436134,7.96481196983514,SLC8A1,KEGG_2019_Mouse,magenta
Bile secretion,1/72,0.19191854685501,0.343589546477276,0,0,4.8251578436134,7.96481196983514,KCNN2,KEGG_2019_Mouse,magenta
Renin secretion,1/76,0.201446644139077,0.343589546477276,0,0,4.56689655172414,7.31722197769891,ADORA1,KEGG_2019_Mouse,magenta
Cardiac muscle contraction,1/78,0.206169189854455,0.343589546477276,0,0,4.44782803403493,7.02337905049818,SLC8A1,KEGG_2019_Mouse,magenta
Salivary secretion,1/78,0.206169189854455,0.343589546477276,0,0,4.44782803403493,7.02337905049818,RYR3,KEGG_2019_Mouse,magenta
ECM-receptor interaction,1/83,0.217855768580715,0.343589546477276,0,0,4.1755677039529,6.36323968350455,COL6A1,KEGG_2019_Mouse,magenta
Hypertrophic cardiomyopathy (HCM),1/86,0.224786357879631,0.343589546477276,0,0,4.02758620689655,6.01159469973406,SLC8A1,KEGG_2019_Mouse,magenta
Insulin secretion,1/86,0.224786357879631,0.343589546477276,0,0,4.02758620689655,6.01159469973406,KCNN2,KEGG_2019_Mouse,magenta
Dilated cardiomyopathy (DCM),1/90,0.233933308239848,0.343589546477276,0,0,3.84579620302208,5.58686202867775,SLC8A1,KEGG_2019_Mouse,magenta
GABAergic synapse,1/90,0.233933308239848,0.343589546477276,0,0,3.84579620302208,5.58686202867775,GABRA5,KEGG_2019_Mouse,magenta
Sphingolipid signaling pathway,1/124,0.307517771581039,0.437979856494207,0,0,2.77796467619849,3.27583817159884,ADORA1,KEGG_2019_Mouse,magenta
Relaxin signaling pathway,1/131,0.321781347862006,0.441804031337563,0,0,2.62745358090186,2.97922496969147,RXFP1,KEGG_2019_Mouse,magenta
Adrenergic signaling in cardiomyocytes,1/148,0.355229995282536,0.441804031337563,0,0,2.32160450387051,2.40283703976331,SLC8A1,KEGG_2019_Mouse,magenta
Phospholipase D signaling pathway,1/149,0.357146243795974,0.441804031337563,0,0,2.30580149114632,2.37407612249373,GRM8,KEGG_2019_Mouse,magenta
Retrograde endocannabinoid signaling,1/150,0.359056893436899,0.441804031337563,0,0,2.29021059939829,2.34580414599556,GABRA5,KEGG_2019_Mouse,magenta
mTOR signaling pathway,1/154,0.366643824754671,0.441804031337563,0,0,2.22988505747126,2.23738729820703,RNF152,KEGG_2019_Mouse,magenta
Oxytocin signaling pathway,1/154,0.366643824754671,0.441804031337563,0,0,2.22988505747126,2.23738729820703,RYR3,KEGG_2019_Mouse,magenta
Cushing syndrome,1/159,0.376003430925586,0.441804031337563,0,0,2.15877346137058,2.11161939603723,PBX1,KEGG_2019_Mouse,magenta
Alzheimer disease,1/175,0.405049754475918,0.464325328301662,0,0,1.95868014268728,1.77014810803811,RYR3,KEGG_2019_Mouse,magenta
Focal adhesion,1/199,0.446143919134405,0.499256290459929,0,0,1.71917450365726,1.38756927804145,COL6A1,KEGG_2019_Mouse,magenta
Human T-cell leukemia virus 1 infection,1/245,0.517258972146992,0.565376085835084,0,0,1.39181741096665,0.917502205558217,NRP1,KEGG_2019_Mouse,magenta
MicroRNAs in cancer,1/281,0.566580094774211,0.605210555781544,0,0,1.21065270935961,0.687816384300004,ZFPM2,KEGG_2019_Mouse,magenta
PI3K-Akt signaling pathway,1/357,0.655002505981749,0.672408607888071,0,0,0.948518016272762,0.401333355207518,COL6A1,KEGG_2019_Mouse,magenta
Human papillomavirus infection,1/360,0.658102041762793,0.672408607888071,0,0,0.940447603496302,0.393478839343228,COL6A1,KEGG_2019_Mouse,magenta
Olfactory transduction,1/1133,0.968122208508771,0.968122208508771,0,0,0.286478006579749,0.0092810140032636,SLC8A1,KEGG_2019_Mouse,magenta
Glutamatergic synapse,9/114,5.6875477630323505e-09,5.17566846435943e-07,0,0,18.6452119309262,353.979099684716,GRIN2A;HOMER1;SLC1A2;DLGAP1;SLC17A7;GRIN2B;GRIA3;GLS;GRIN1,KEGG_2019_Mouse,brown
Amphetamine addiction,7/68,4.76966118328738e-08,2.17019583839576e-06,0,0,24.4796404019038,412.687703712181,CAMK2B;GRIN2A;CAMK2A;GRIN2B;STX1A;GRIA3;GRIN1,KEGG_2019_Mouse,brown
Circadian entrainment,7/99,6.45617315635044e-07,1.95837252409297e-05,0,0,16.205703599813,230.980847913613,CAMK2B;RYR2;GRIN2A;CAMK2A;GRIN2B;GRIA3;GRIN1,KEGG_2019_Mouse,brown
cAMP signaling pathway,9/211,1.13229113209364e-06,2.57596232551302e-05,0,0,9.64432597105864,132.043046026986,CAMK2B;RYR2;GRIN2A;CAMK2A;ATP2B2;ATP2B1;GRIN2B;GRIA3;GRIN1,KEGG_2019_Mouse,brown
Nicotine addiction,5/40,1.61784357056159e-06,2.9444752984221e-05,0,0,29.8721804511278,398.328093650392,GRIN2A;SLC17A7;GRIN2B;GRIA3;GRIN1,KEGG_2019_Mouse,brown
Insulin secretion,6/86,4.57011626728069e-06,6.31740984466315e-05,0,0,15.813829787234,194.446406884405,CAMK2B;SNAP25;RYR2;KCNMA1;CAMK2A;STX1A,KEGG_2019_Mouse,brown
Calcium signaling pathway,8/189,4.85954603435627e-06,6.31740984466315e-05,0,0,9.47345664184482,115.903626108527,CAMK2B;RYR2;GRIN2A;CAMK2A;ATP2B2;ATP2B1;CACNA1E;GRIN1,KEGG_2019_Mouse,brown
Adrenergic signaling in cardiomyocytes,7/148,9.49481976294159e-06,0.0001080035748034,0,0,10.5477770151758,121.98255397453,CAMK2B;RYR2;CACNA2D1;CAMK2A;ATP2B2;ATP2B1;CACNG3,KEGG_2019_Mouse,brown
Oxytocin signaling pathway,7/154,1.23078799385532e-05,0.0001244463416009,0,0,10.1141833077317,114.343581774068,CAMK2B;RYR2;MEF2C;CACNA2D1;CAMK2A;CACNG3;CAMKK2,KEGG_2019_Mouse,brown
Long-term potentiation,5/67,2.13419841401958e-05,0.0001942120556757,0,0,16.8404074702886,181.115792542471,CAMK2B;GRIN2A;CAMK2A;GRIN2B;GRIN1,KEGG_2019_Mouse,brown
Amyotrophic lateral sclerosis (ALS),4/52,0.0001324843517277,0.0010960069097473,0,0,17.2326388888889,153.871025679427,GRIN2A;SLC1A2;GRIN2B;GRIN1,KEGG_2019_Mouse,brown
Aldosterone synthesis and secretion,5/102,0.0001603355954379,0.0012158782654048,0,0,10.7449810092241,93.8922386262267,CAMK2B;KCNK9;CAMK2A;ATP2B2;ATP2B1,KEGG_2019_Mouse,brown
Dopaminergic synapse,5/135,0.0005861755900727,0.0039126510702351,0,0,8.00404858299595,59.5652584861222,CAMK2B;GRIN2A;CAMK2A;GRIN2B;GRIA3,KEGG_2019_Mouse,brown
Synaptic vesicle cycle,4/77,0.0006019463184977,0.0039126510702351,0,0,11.3167808219178,83.9178033991571,SNAP25;SLC1A2;SLC17A7;STX1A,KEGG_2019_Mouse,brown
Cocaine addiction,3/48,0.0017818416942912,0.0108098396120337,0,0,13.6460481099656,86.3809554416349,GRIN2A;GRIN2B;GRIN1,KEGG_2019_Mouse,brown
Pancreatic secretion,4/105,0.001911353052285,0.010870820484871,0,0,8.16790429042904,51.130622502952,RYR2;KCNMA1;ATP2B2;ATP2B1,KEGG_2019_Mouse,brown
Arrhythmogenic right ventricular cardiomyopathy (ARVC),3/72,0.0056354324907242,0.0301661386268181,0,0,8.88883908561183,46.0324654948436,RYR2;CACNA2D1;CACNG3,KEGG_2019_Mouse,brown
Cardiac muscle contraction,3/78,0.0070353356395665,0.0336955549052923,0,0,8.17525773195876,40.5231982940018,RYR2;CACNA2D1;CACNG3,KEGG_2019_Mouse,brown
Salivary secretion,3/78,0.0070353356395665,0.0336955549052923,0,0,8.17525773195876,40.5231982940018,KCNMA1;ATP2B2;ATP2B1,KEGG_2019_Mouse,brown
Hypertrophic cardiomyopathy (HCM),3/86,0.0091967042793181,0.0418450044708977,0,0,7.38430008694572,34.6243191824314,RYR2;CACNA2D1;CACNG3,KEGG_2019_Mouse,brown
Dilated cardiomyopathy (DCM),3/90,0.0104072034150418,0.045097881465181,0,0,7.04337006754355,32.1547950435062,RYR2;CACNA2D1;CACNG3,KEGG_2019_Mouse,brown
cGMP-PKG signaling pathway,4/172,0.0109278197077072,0.0452014360636981,0,0,4.89384920634921,22.1027933131365,MEF2C;KCNMA1;ATP2B2;ATP2B1,KEGG_2019_Mouse,brown
MAPK signaling pathway,5/294,0.0160935082886768,0.0636743154030257,0,0,3.57148060462575,14.7478552205364,MEF2C;CACNA2D1;CACNA1E;RASGRP1;CACNG3,KEGG_2019_Mouse,brown
Alcoholism,4/199,0.0177783315627962,0.0674095071756023,0,0,4.21047008547009,16.9672466304178,GRIN2A;GRIN2B;CAMKK2;GRIN1,KEGG_2019_Mouse,brown
Cholinergic synapse,3/113,0.0191074760635156,0.0695512128711968,0,0,5.56419868791003,22.0212934005866,CAMK2B;KCNQ2;CAMK2A,KEGG_2019_Mouse,brown
Rap1 signaling pathway,4/209,0.020866029454326,0.0730311030901411,0,0,4.0030487804878,15.4903289704313,GRIN2A;SIPA1L1;GRIN2B;GRIN1,KEGG_2019_Mouse,brown
Neurotrophin signaling pathway,3/121,0.0228427106038633,0.0769883949982059,0,0,5.18486807618382,19.5942553564973,CAMK2B;CAMK2A;MATK,KEGG_2019_Mouse,brown
Ras signaling pathway,4/233,0.0295572342532096,0.0960610113229313,0,0,3.57914847161572,12.6037091741373,GRIN2A;RASGRP1;GRIN2B;GRIN1,KEGG_2019_Mouse,brown
Gastric acid secretion,2/74,0.0529880944930012,0.164609565518054,0,0,5.62018140589569,16.5103396024628,CAMK2B;CAMK2A,KEGG_2019_Mouse,brown
Glioma,2/75,0.0542668897312266,0.164609565518054,0,0,5.54291305563321,16.1511673406941,CAMK2B;CAMK2A,KEGG_2019_Mouse,brown
Alzheimer disease,3/175,0.0575615219120738,0.168970919161249,0,0,3.54735075521458,10.1273350654031,GRIN2A;GRIN2B;GRIN1,KEGG_2019_Mouse,brown
ErbB signaling pathway,2/84,0.0662504359060044,0.1883996771077,0,0,4.93230462916874,13.3878197311643,CAMK2B;CAMK2A,KEGG_2019_Mouse,brown
GnRH signaling pathway,2/90,0.0746819496854828,0.20594113398118,0,0,4.59461966604824,11.9208181587653,CAMK2B;CAMK2A,KEGG_2019_Mouse,brown
Melanogenesis,2/100,0.0894369333512962,0.232429667098594,0,0,4.12369845897543,9.95552171579456,CAMK2B;CAMK2A,KEGG_2019_Mouse,brown
Arginine biosynthesis,1/19,0.0908825145361798,0.232429667098594,0,0,11.1571268237935,26.7568838212325,GLS,KEGG_2019_Mouse,brown
Glucagon signaling pathway,2/102,0.0924846891098034,0.232429667098594,0,0,4.04081632653061,9.62002061056518,CAMK2B;CAMK2A,KEGG_2019_Mouse,brown
HIF-1 signaling pathway,2/104,0.0955625544444408,0.232429667098594,0,0,3.96118447378952,9.30075904717404,CAMK2B;CAMK2A,KEGG_2019_Mouse,brown
Neuroactive ligand-receptor interaction,4/348,0.0970585423049072,0.232429667098594,0,0,2.3687015503876,5.52485650300949,GRIN2A;GRIN2B;GRIA3;GRIN1,KEGG_2019_Mouse,brown
Proximal tubule bicarbonate reclamation,1/22,0.104464697819105,0.243750961577912,0,0,9.56180856180856,21.5992275397069,GLS,KEGG_2019_Mouse,brown
Oocyte meiosis,2/116,0.114613258295413,0.260745162622065,0,0,3.54206945936269,7.67280178057288,CAMK2B;CAMK2A,KEGG_2019_Mouse,brown
Inflammatory mediator regulation of TRP channels,2/127,0.132846507942149,0.294854444456965,0,0,3.22857142857143,6.5170680254594,CAMK2B;CAMK2A,KEGG_2019_Mouse,brown
Apelin signaling pathway,2/138,0.151685215687714,0.322879258598692,0,0,2.96578631452581,5.59331833808979,RYR2;MEF2C,KEGG_2019_Mouse,brown
SNARE interactions in vesicular transport,1/33,0.152569319997184,0.322879258598692,0,0,6.27146464646465,11.7912078898077,STX1A,KEGG_2019_Mouse,brown
Systemic lupus erythematosus,2/143,0.160416714470738,0.331770932200845,0,0,2.85989289332754,5.23354789527023,GRIN2A;GRIN2B,KEGG_2019_Mouse,brown
"Alanine, aspartate and glutamate metabolism",1/37,0.169420067180126,0.341826322968283,0,0,5.57351290684624,9.89507014564132,GLS,KEGG_2019_Mouse,brown
Retrograde endocannabinoid signaling,2/150,0.172791328093857,0.341826322968283,0,0,2.72366243794815,4.7818540898178,SLC17A7;GRIA3,KEGG_2019_Mouse,brown
Cushing syndrome,2/159,0.188921090423562,0.361585602047548,0,0,2.56635902768751,4.27664705514897,CAMK2B;CAMK2A,KEGG_2019_Mouse,brown
Wnt signaling pathway,2/160,0.190726471409696,0.361585602047548,0,0,2.54998708344097,4.22511175710114,CAMK2B;CAMK2A,KEGG_2019_Mouse,brown
Mineral absorption,1/44,0.1981144149655,0.367926770650214,0,0,4.6645525017618,7.55149331126355,ATP2B1,KEGG_2019_Mouse,brown
Cell adhesion molecules (CAMs),2/170,0.208900201139448,0.380198366073795,0,0,2.39698736637512,3.75343927524843,NRXN1;NRCAM,KEGG_2019_Mouse,brown
Type II diabetes mellitus,1/48,0.214068244088033,0.381964906117863,0,0,4.26670964968837,6.57696403663591,CACNA1E,KEGG_2019_Mouse,brown
Necroptosis,2/176,0.219891523272346,0.382953521167715,0,0,2.3136288998358,3.50427075656082,CAMK2B;CAMK2A,KEGG_2019_Mouse,brown
Tuberculosis,2/178,0.223566841614148,0.382953521167715,0,0,2.28710575139147,3.42618697401597,CAMK2B;CAMK2A,KEGG_2019_Mouse,brown
Axon guidance,2/180,0.227247144429194,0.382953521167715,0,0,2.26117862875487,3.35042706699839,CAMK2B;CAMK2A,KEGG_2019_Mouse,brown
Transcriptional misregulation in cancer,2/183,0.232775941528175,0.385138375982981,0,0,2.22336227308603,3.24094830013958,MEF2C;GRIA3,KEGG_2019_Mouse,brown
Endocrine and other factor-regulated calcium reabsorption,1/55,0.241234861655302,0.392006650189865,0,0,3.71230826786382,5.27884403782842,ATP2B1,KEGG_2019_Mouse,brown
Huntington disease,2/192,0.249408486067724,0.398178460213384,0,0,2.11707841031149,2.93990892306422,GRIN2B;GRIN1,KEGG_2019_Mouse,brown
Long-term depression,1/61,0.263779141308675,0.413860376880853,0,0,3.34006734006734,4.45111773409346,GRIA3,KEGG_2019_Mouse,brown
Proteoglycans in cancer,2/203,0.269787257396922,0.416112549544406,0,0,2.00010153315057,2.62037615304045,CAMK2B;CAMK2A,KEGG_2019_Mouse,brown
Central carbon metabolism in cancer,1/64,0.274801310842782,0.416781988111553,0,0,3.18053551386885,4.10831982313615,GLS,KEGG_2019_Mouse,brown
Regulation of actin cytoskeleton,2/217,0.295709072188337,0.438246556019502,0,0,1.86853345989559,2.27658225012256,CYFIP2;BAIAP2,KEGG_2019_Mouse,brown
Adipocytokine signaling pathway,1/71,0.299888438313403,0.438246556019502,0,0,2.86147186147186,3.44619860155019,CAMKK2,KEGG_2019_Mouse,brown
Adherens junction,1/72,0.303401461859655,0.438246556019502,0,0,2.82102717313985,3.36463457832852,BAIAP2,KEGG_2019_Mouse,brown
Bacterial invasion of epithelial cells,1/74,0.310375237892897,0.441314791378963,0,0,2.74346201743462,3.20977722405069,SEPT11,KEGG_2019_Mouse,brown
Renin secretion,1/76,0.317279889350664,0.44419184509093,0,0,2.67003367003367,3.0651211233087,KCNMA1,KEGG_2019_Mouse,brown
ECM-receptor interaction,1/83,0.340911546721369,0.470044708358251,0,0,2.44124168514412,2.62709885646942,SV2B,KEGG_2019_Mouse,brown
Taste transduction,1/88,0.357293708483398,0.485279514507302,0,0,2.30035992104958,2.36752381170365,SCN2A,KEGG_2019_Mouse,brown
GABAergic synapse,1/90,0.363733115678147,0.486760493039874,0,0,2.24843945068664,2.27392523969427,GLS,KEGG_2019_Mouse,brown
T cell receptor signaling pathway,1/101,0.398024694482133,0.521364795113945,0,0,2.0,1.84248245836996,RASGRP1,KEGG_2019_Mouse,brown
Longevity regulating pathway,1/102,0.401049842395342,0.521364795113945,0,0,1.98009800980098,1.80915528558786,CAMKK2,KEGG_2019_Mouse,brown
"Parathyroid hormone synthesis, secretion and action",1/107,0.41595129052059,0.533120668132024,0,0,1.88622069754145,1.65456849319568,MEF2C,KEGG_2019_Mouse,brown
TNF signaling pathway,1/110,0.424715362613925,0.536793027748155,0,0,1.83402835696414,1.57054463447437,CX3CL1,KEGG_2019_Mouse,brown
Platelet activation,1/125,0.46662037707619,0.576258974639143,0,0,1.61094819159335,1.22792793965158,RASGRP1,KEGG_2019_Mouse,brown
AMPK signaling pathway,1/126,0.469304042324134,0.576258974639143,0,0,1.5979797979798,1.20887881651748,CAMKK2,KEGG_2019_Mouse,brown
Autophagy,1/130,0.479905677193982,0.576258974639143,0,0,1.54811682718659,1.13657427447839,CAMKK2,KEGG_2019_Mouse,brown
FoxO signaling pathway,1/132,0.485127594032975,0.576258974639143,0,0,1.52432724188449,1.1026119616962,HOMER1,KEGG_2019_Mouse,brown
Ubiquitin mediated proteolysis,1/138,0.500483918197201,0.576258974639143,0,0,1.45712600457126,1.00859320422095,FBXW7,KEGG_2019_Mouse,brown
Pathways in cancer,3/535,0.502893268361744,0.576258974639143,0,0,1.12595922796682,0.773958838275883,CAMK2B;CAMK2A;RASGRP1,KEGG_2019_Mouse,brown
Vascular smooth muscle contraction,1/140,0.505501237241334,0.576258974639143,0,0,1.43601482450403,0.979656196045578,KCNMA1,KEGG_2019_Mouse,brown
Apoptosis,1/141,0.507991154544595,0.576258974639143,0,0,1.42568542568543,0.965604255328444,SPTAN1,KEGG_2019_Mouse,brown
Fluid shear stress and atherosclerosis,1/143,0.512933812590885,0.576258974639143,0,0,1.40546308151942,0.938299046849509,MEF2C,KEGG_2019_Mouse,brown
Hippo signaling pathway,1/159,0.550745324592532,0.611192982169761,0,0,1.26211481907684,0.75282975911799,DLG2,KEGG_2019_Mouse,brown
Tight junction,1/167,0.568546217907677,0.615925069399983,0,0,1.20080321285141,0.678060757672765,DLG2,KEGG_2019_Mouse,brown
RNA transport,1/167,0.568546217907677,0.615925069399983,0,0,1.20080321285141,0.678060757672765,CYFIP2,KEGG_2019_Mouse,brown
Chemokine signaling pathway,1/197,0.62929598455177,0.673716877578953,0,0,1.01546072974644,0.470314261452597,CX3CL1,KEGG_2019_Mouse,brown
Human cytomegalovirus infection,1/255,0.723736859618685,0.76581458401512,0,0,0.781277340332458,0.252608375993645,CX3CL1,KEGG_2019_Mouse,brown
Endocytosis,1/269,0.742699014212871,0.776846095326106,0,0,0.739936680235188,0.220104829214578,PSD3,KEGG_2019_Mouse,brown
MicroRNAs in cancer,1/281,0.757922669215417,0.783760942029579,0,0,0.707792207792208,0.196181539398202,GLS,KEGG_2019_Mouse,brown
Cytokine-cytokine receptor interaction,1/292,0.771092573236891,0.788420496230979,0,0,0.680655350758444,0.176934209993707,CX3CL1,KEGG_2019_Mouse,brown
Human papillomavirus infection,1/360,0.838126716029775,0.847439235096772,0,0,0.549815705804564,0.0970897438463633,DLG2,KEGG_2019_Mouse,brown
Olfactory transduction,2/1133,0.97966519325239,0.97966519325239,0,0,0.338674461827171,0.0069578653841452,CAMK2B;CAMK2A,KEGG_2019_Mouse,brown
Oxidative phosphorylation,12/134,3.15645093933697e-12,4.98719248415242e-10,0,0,22.1065573770492,585.416409421196,ATP6V1A;ATP5B;NDUFA13;NDUFB8;NDUFA4;COX4I1;ATP5J;NDUFC2;ATP6V0E2;ATP6V1D;ATP6V0C;COX6B1,KEGG_2019_Mouse,yellow
Parkinson disease,12/144,7.4524125315912e-12,5.88740589995705e-10,0,0,20.4214876033058,523.249225203775,ATP5B;NDUFA13;UCHL1;NDUFB8;UBB;NDUFA4;COX4I1;ATP5J;NDUFC2;VDAC1;SLC25A4;COX6B1,KEGG_2019_Mouse,yellow
Ribosome,12/170,5.2876059405049094e-11,2.7848057953325804e-09,0,0,17.0385500575374,403.184410253549,RPL3;RPS16;RPS7;RPS8;RPS3A1;RPS5;RPSA;FAU;RPL8;RPL28;UBA52;RPL19,KEGG_2019_Mouse,yellow
Huntington disease,11/192,3.22517029603817e-09,1.27394226693508e-07,0,0,13.4650816313862,263.273047398933,ATP5B;NDUFA13;NDUFB8;NDUFA4;COX4I1;ATP5J;NDUFC2;VDAC1;SLC25A4;AP2M1;COX6B1,KEGG_2019_Mouse,yellow
Alzheimer disease,10/175,1.78400951387208e-08,5.63747006383578e-07,0,0,13.2895622895623,237.109943389584,ATP5B;NDUFA13;NDUFB8;NDUFA4;COX4I1;ATP5J;NDUFC2;CALM2;GAPDH;COX6B1,KEGG_2019_Mouse,yellow
Phagosome,10/180,2.33367839277982e-08,6.14535310098685e-07,0,0,12.8954248366013,226.614331231614,ATP6V1A;TUBA1B;TUBB5;TUBB2A;TUBB3;ATP6V0E2;TUBB4B;ATP6V1D;ATP6V0C;ACTG1,KEGG_2019_Mouse,yellow
Glycolysis / Gluconeogenesis,7/67,4.29612224856582e-08,9.69696164676285e-07,0,0,24.8888888888889,422.189424054984,LDHB;TPI1;PKM;PGK1;ENO1;ALDOA;GAPDH,KEGG_2019_Mouse,yellow
Thermogenesis,10/231,2.42771539787445e-07,4.79473791080204e-06,0,0,9.89391654097536,150.695677466578,ATP5B;NDUFA13;NDUFB8;NDUFA4;COX4I1;GNAS;ATP5J;NDUFC2;ACTG1;COX6B1,KEGG_2019_Mouse,yellow
Gap junction,6/86,4.57011626728069e-06,8.02309300255943e-05,0,0,15.813829787234,194.446406884405,TUBA1B;TUBB5;TUBB2A;TUBB3;GNAS;TUBB4B,KEGG_2019_Mouse,yellow
Collecting duct acid secretion,4/27,9.45158425012631e-06,0.0001493350311519,0,0,36.0090579710145,416.600609299125,ATP6V1A;ATP6V0E2;ATP6V1D;ATP6V0C,KEGG_2019_Mouse,yellow
Pyruvate metabolism,4/38,3.81116028676401e-05,0.0005474212048261,0,0,24.3455882352941,247.716160294751,LDHB;PKM;MDH1;MDH2,KEGG_2019_Mouse,yellow
Synaptic vesicle cycle,5/77,4.19721730027379e-05,0.0005526336112027,0,0,14.4941520467836,146.079365130669,ATP6V1A;ATP6V0E2;ATP6V0C;ATP6V1D;AP2M1,KEGG_2019_Mouse,yellow
Estrogen signaling pathway,6/134,5.75328536126532e-05,0.0006992454515999,0,0,9.85970744680851,96.2618462026828,HSPA8;HSP90AA1;HSP90AB1;GNAS;CALM2;HSP90B1,KEGG_2019_Mouse,yellow
Antigen processing and presentation,5/90,8.86973558876199e-05,0.001001013016446,0,0,12.2693498452012,114.476475347056,HSPA8;HSP90AA1;HSP90AB1;HSPA5;CTSB,KEGG_2019_Mouse,yellow
Non-alcoholic fatty liver disease (NAFLD),6/151,0.0001114667936437,0.001121476189566,0,0,8.6962582538518,79.1514627240073,NDUFA13;NDUFB8;NDUFA4;COX4I1;NDUFC2;COX6B1,KEGG_2019_Mouse,yellow
Cysteine and methionine metabolism,4/50,0.0001135672090699,0.001121476189566,0,0,17.9836956521739,163.347989147706,LDHB;GOT1;MDH1;MDH2,KEGG_2019_Mouse,yellow
Protein processing in endoplasmic reticulum,6/163,0.0001693432645465,0.0015738962234322,0,0,8.02669738446944,69.7004909623148,HSPA8;HSP90AA1;HSP90AB1;HSPA5;SKP1A;HSP90B1,KEGG_2019_Mouse,yellow
Necroptosis,6/176,0.0002565169032023,0.0022516483725539,0,0,7.40801001251564,61.2517676857547,HSP90AA1;HSP90AB1;H2AFZ;VDAC1;PPIA;SLC25A4,KEGG_2019_Mouse,yellow
Fluid shear stress and atherosclerosis,5/143,0.000760747708216,0.0063262177841122,0,0,7.53699466056445,54.1247322442528,HSP90AA1;HSP90AB1;CALM2;ACTG1;HSP90B1,KEGG_2019_Mouse,yellow
Rheumatoid arthritis,4/84,0.0008356618925326,0.0066017289510075,0,0,10.3229166666667,73.1614675343946,ATP6V1A;ATP6V0E2;ATP6V0C;ATP6V1D,KEGG_2019_Mouse,yellow
Retrograde endocannabinoid signaling,5/150,0.0009430578939102,0.0070953879637056,0,0,7.17059891107078,49.9531375212897,NDUFA13;NDUFB8;GNG3;NDUFA4;NDUFC2,KEGG_2019_Mouse,yellow
Glucagon signaling pathway,4/102,0.0017186513921803,0.0123430418165676,0,0,8.41921768707483,53.5985530429797,LDHB;PKM;GNAS;CALM2,KEGG_2019_Mouse,yellow
HIF-1 signaling pathway,4/104,0.0018455372762019,0.0126780386799959,0,0,8.25,51.9336249074655,PGK1;ENO1;ALDOA;GAPDH,KEGG_2019_Mouse,yellow
Legionellosis,3/58,0.0030661973063982,0.0201857989337885,0,0,11.1593252108716,64.5825541481917,EEF1A1;HSPA8;ARF1,KEGG_2019_Mouse,yellow
Alcoholism,5/199,0.0032534014399461,0.0205614971004596,0,0,5.34617471513836,30.6231787075913,GNG3;H3F3B;H2AFZ;GNAS;CALM2,KEGG_2019_Mouse,yellow
NOD-like receptor signaling pathway,5/205,0.0036924982354696,0.0224390277386231,0,0,5.18421052631579,29.0391065321379,GABARAPL1;HSP90AA1;HSP90AB1;VDAC1;CTSB,KEGG_2019_Mouse,yellow
Dopaminergic synapse,4/135,0.0047223337439316,0.0276343974644889,0,0,6.28784987277354,33.674279209969,GNG3;CALY;GNAS;CALM2,KEGG_2019_Mouse,yellow
Phenylalanine metabolism,2/23,0.0058476195920622,0.0319044708365787,0,0,19.3187560738581,99.3316462237063,GOT1;MIF,KEGG_2019_Mouse,yellow
Thyroid hormone synthesis,3/73,0.0058558838877264,0.0319044708365787,0,0,8.76141384388807,45.0363685681287,HSPA5;GNAS;HSP90B1,KEGG_2019_Mouse,yellow
Renin secretion,3/76,0.00654799848395,0.0344861253488037,0,0,8.40008473379466,42.2406312404249,GNAS;CALM2;CTSB,KEGG_2019_Mouse,yellow
Human papillomavirus infection,6/360,0.0094369084319193,0.0480977913626854,0,0,3.52434186801298,16.4344531900758,ATP6V1A;PKM;GNAS;ATP6V0E2;ATP6V1D;ATP6V0C,KEGG_2019_Mouse,yellow
Glyoxylate and dicarboxylate metabolism,2/31,0.0104724512850622,0.0513431631414204,0,0,13.9838142153413,63.7523090878691,MDH1;MDH2,KEGG_2019_Mouse,yellow
IL-17 signaling pathway,3/91,0.0107235720485245,0.0513431631414204,0,0,6.96298031865042,31.5792809907681,HSP90AA1;HSP90AB1;HSP90B1,KEGG_2019_Mouse,yellow
Citrate cycle (TCA cycle),2/32,0.0111345221222249,0.0517427792738686,0,0,13.5170068027211,60.795507674817,MDH1;MDH2,KEGG_2019_Mouse,yellow
Prion diseases,2/34,0.0125124802245356,0.0559080659130188,0,0,12.6709183673469,55.5116572102178,PRNP;HSPA5,KEGG_2019_Mouse,yellow
Prostate cancer,3/97,0.0127385466637258,0.0559080659130188,0,0,6.51656064926519,28.4325537727779,HSP90AA1;HSP90AB1;HSP90B1,KEGG_2019_Mouse,yellow
Fructose and mannose metabolism,2/35,0.0132279832722483,0.0559446522836622,0,0,12.2863327149041,53.1435584472206,TPI1;ALDOA,KEGG_2019_Mouse,yellow
Circadian entrainment,3/99,0.0134550429542985,0.0559446522836622,0,0,6.38015463917526,27.4882665567256,GNG3;GNAS;CALM2,KEGG_2019_Mouse,yellow
Calcium signaling pathway,4/189,0.014993672320653,0.0607435955554661,0,0,4.44031531531532,18.6498882984146,GNAS;VDAC1;CALM2;SLC25A4,KEGG_2019_Mouse,yellow
Tyrosine metabolism,2/40,0.0170631829128301,0.0673995725056791,0,0,10.6670247046187,43.4236674606069,GOT1;MIF,KEGG_2019_Mouse,yellow
Pathways in cancer,7/535,0.0178468603153819,0.068775705605618,0,0,2.76156728576083,11.1178701729531,HSP90AA1;GNG3;HSP90AB1;GNAS;SKP1A;CALM2;HSP90B1,KEGG_2019_Mouse,yellow
Oocyte meiosis,3/116,0.0204649473810009,0.0769871830047177,0,0,5.4156555058845,21.0617103129901,YWHAE;SKP1A;CALM2,KEGG_2019_Mouse,yellow
Kaposi sarcoma-associated herpesvirus infection,4/216,0.0232120303934508,0.0852907163294237,0,0,3.86949685534591,14.5612439613615,GABARAPL1;GNG3;UBB;CALM2,KEGG_2019_Mouse,yellow
Lysosome,3/124,0.0243385983169026,0.0872467680953304,0,0,5.05555082218625,18.7848686370022,PSAP;ATP6V0C;CTSB,KEGG_2019_Mouse,yellow
Platelet activation,3/125,0.0248487630651258,0.0872467680953304,0,0,5.0138583741761,18.5259424809443,GNAS;ACTG1;MYL12B,KEGG_2019_Mouse,yellow
Endocrine and other factor-regulated calcium reabsorption,2/55,0.030955668405524,0.105347328992826,0,0,7.64227955333077,26.5584434034501,GNAS;AP2M1,KEGG_2019_Mouse,yellow
Human immunodeficiency virus 1 infection,4/238,0.0316007668326221,0.105347328992826,0,0,3.50178062678063,12.0971599281875,GNG3;CFL1;SKP1A;CALM2,KEGG_2019_Mouse,yellow
Apelin signaling pathway,3/138,0.0320042518459219,0.105347328992826,0,0,4.52806414662085,15.5850829245115,GABARAPL1;GNG3;CALM2,KEGG_2019_Mouse,yellow
PI3K-Akt signaling pathway,5/357,0.0335343128615864,0.106785427392858,0,0,2.92284688995215,9.92360913268854,YWHAE;HSP90AA1;GNG3;HSP90AB1;HSP90B1,KEGG_2019_Mouse,yellow
Apoptosis,3/141,0.0337928567698919,0.106785427392858,0,0,4.42895562528014,15.0031130324376,TUBA1B;ACTG1;CTSB,KEGG_2019_Mouse,yellow
"Phenylalanine, tyrosine and tryptophan biosynthesis",1/8,0.0393135041520565,0.120571935776538,0,0,28.7056277056277,92.8967850071638,GOT1,KEGG_2019_Mouse,yellow
Mitophagy,2/63,0.0396819029137974,0.120571935776538,0,0,6.6373369019739,21.4177572290841,GABARAPL1;UBB,KEGG_2019_Mouse,yellow
Oxytocin signaling pathway,3/154,0.0421306259009563,0.12559696023304,0,0,4.04499214856285,12.8104106369815,GNAS;CALM2;ACTG1,KEGG_2019_Mouse,yellow
Amphetamine addiction,2/68,0.0455522545652316,0.13242641120603,0,0,6.13296227581942,18.9440774902941,GNAS;CALM2,KEGG_2019_Mouse,yellow
Endocytosis,4/269,0.0460978013691878,0.13242641120603,0,0,3.0872641509434,9.49948099007502,HSPA8;ARF1;UBB;AP2M1,KEGG_2019_Mouse,yellow
Tight junction,3/167,0.0514036895977325,0.144346878101624,0,0,3.72190093034951,11.0467706640303,TUBA1B;ACTG1;MYL12B,KEGG_2019_Mouse,yellow
Influenza A,3/168,0.0521548749739569,0.144346878101624,0,0,3.6991565135895,10.9255979327696,HSPA8;VDAC1;ACTG1,KEGG_2019_Mouse,yellow
Gastric acid secretion,2/74,0.0529880944930012,0.144346878101624,0,0,5.62018140589569,16.5103396024628,GNAS;CALM2,KEGG_2019_Mouse,yellow
cGMP-PKG signaling pathway,3/172,0.0552127694919147,0.146299023925512,0,0,3.61087049350332,10.4591067236381,VDAC1;CALM2;SLC25A4,KEGG_2019_Mouse,yellow
Pertussis,2/76,0.0555565913641186,0.146299023925512,0,0,5.46773303916161,15.8036792136142,CFL1;CALM2,KEGG_2019_Mouse,yellow
Cardiac muscle contraction,2/78,0.058168160710821,0.148234990198544,0,0,5.32330827067669,15.1417092906877,COX4I1;COX6B1,KEGG_2019_Mouse,yellow
Salivary secretion,2/78,0.058168160710821,0.148234990198544,0,0,5.32330827067669,15.1417092906877,GNAS;CALM2,KEGG_2019_Mouse,yellow
Cellular senescence,3/185,0.0657265644838414,0.164838050610269,0,0,3.35074204146369,9.12156457624841,VDAC1;CALM2;SLC25A4,KEGG_2019_Mouse,yellow
Dilated cardiomyopathy (DCM),2/90,0.0746819496854828,0.176115642541885,0,0,4.59461966604824,11.9208181587653,GNAS;ACTG1,KEGG_2019_Mouse,yellow
GABAergic synapse,2/90,0.0746819496854828,0.176115642541885,0,0,4.59461966604824,11.9208181587653,GABARAPL1;GNG3,KEGG_2019_Mouse,yellow
GnRH signaling pathway,2/90,0.0746819496854828,0.176115642541885,0,0,4.59461966604824,11.9208181587653,GNAS;CALM2,KEGG_2019_Mouse,yellow
Progesterone-mediated oocyte maturation,2/90,0.0746819496854828,0.176115642541885,0,0,4.59461966604824,11.9208181587653,HSP90AA1;HSP90AB1,KEGG_2019_Mouse,yellow
Morphine addiction,2/92,0.0775653030615549,0.180225262995966,0,0,4.49206349206349,11.484567093173,GNG3;GNAS,KEGG_2019_Mouse,yellow
Rap1 signaling pathway,3/209,0.0873302976244391,0.199973724995092,0,0,2.95676108497648,7.2087544984596,GNAS;CALM2;ACTG1,KEGG_2019_Mouse,yellow
Melanogenesis,2/100,0.0894369333512962,0.200172340812999,0,0,4.12369845897543,9.95552171579456,GNAS;CALM2,KEGG_2019_Mouse,yellow
Arginine biosynthesis,1/19,0.0908825145361798,0.200172340812999,0,0,11.1571268237935,26.7568838212325,GOT1,KEGG_2019_Mouse,yellow
Aldosterone synthesis and secretion,2/102,0.0924846891098034,0.200172340812999,0,0,4.04081632653061,9.62002061056518,GNAS;CALM2,KEGG_2019_Mouse,yellow
Th17 cell differentiation,2/102,0.0924846891098034,0.200172340812999,0,0,4.04081632653061,9.62002061056518,HSP90AA1;HSP90AB1,KEGG_2019_Mouse,yellow
Regulation of actin cytoskeleton,3/217,0.0951224688379078,0.203099325356614,0,0,2.84507177955487,6.69328762257793,CFL1;ACTG1;MYL12B,KEGG_2019_Mouse,yellow
Proximal tubule bicarbonate reclamation,1/22,0.104464697819105,0.220072296738915,0,0,9.56180856180856,21.5992275397069,MDH1,KEGG_2019_Mouse,yellow
Glutamatergic synapse,2/114,0.111372908000063,0.23153841400013,0,0,3.60568513119534,7.91401436691998,GNG3;GNAS,KEGG_2019_Mouse,yellow
Leukocyte transendothelial migration,2/115,0.112990010336963,0.231849631600521,0,0,3.57359581000542,7.7920679547705,ACTG1;MYL12B,KEGG_2019_Mouse,yellow
Neurotrophin signaling pathway,2/121,0.122818201919793,0.248785588504196,0,0,3.39238552563883,7.11400223667125,YWHAE;CALM2,KEGG_2019_Mouse,yellow
Cell cycle,2/123,0.126139752927233,0.250146868548083,0,0,3.33597571259909,6.90668681067367,YWHAE;SKP1A,KEGG_2019_Mouse,yellow
Phototransduction,1/27,0.126656642302827,0.250146868548083,0,0,7.72105672105672,15.9538300108164,CALM2,KEGG_2019_Mouse,yellow
Protein export,1/28,0.131029255394866,0.253725414933069,0,0,7.43471754582866,15.1098341340557,HSPA5,KEGG_2019_Mouse,yellow
Inflammatory mediator regulation of TRP channels,2/127,0.132846507942149,0.253725414933069,0,0,3.22857142857143,6.5170680254594,GNAS;CALM2,KEGG_2019_Mouse,yellow
Fatty acid elongation,1/29,0.13538019382269,0.253725414933069,0,0,7.16883116883117,14.3352837783296,TECR,KEGG_2019_Mouse,yellow
Human cytomegalovirus infection,3/255,0.135683895261214,0.253725414933069,0,0,2.41138929798724,4.81657505146102,GNG3;GNAS;CALM2,KEGG_2019_Mouse,yellow
Autophagy,2/130,0.137929359831855,0.253725414933069,0,0,3.15242346938776,6.24499379784287,GABARAPL1;CTSB,KEGG_2019_Mouse,yellow
Relaxin signaling pathway,2/131,0.139633215691308,0.253725414933069,0,0,3.12782787533618,6.15786790988172,GNG3;GNAS,KEGG_2019_Mouse,yellow
Circadian rhythm,1/30,0.139709563918842,0.253725414933069,0,0,6.92128178335075,13.6223945108193,SKP1A,KEGG_2019_Mouse,yellow
Serotonergic synapse,2/132,0.141341709574619,0.253772614918065,0,0,3.10361067503925,6.07244658574773,GNG3;GNAS,KEGG_2019_Mouse,yellow
Propanoate metabolism,1/31,0.144017471501311,0.255671466260755,0,0,6.69023569023569,12.9644769200402,LDHB,KEGG_2019_Mouse,yellow
Biosynthesis of unsaturated fatty acids,1/32,0.148304021933978,0.257494895226028,0,0,6.47409579667644,12.3557529781019,TECR,KEGG_2019_Mouse,yellow
Pentose phosphate pathway,1/32,0.148304021933978,0.257494895226028,0,0,6.47409579667644,12.3557529781019,ALDOA,KEGG_2019_Mouse,yellow
Vascular smooth muscle contraction,2/140,0.155166268510966,0.266481200268832,0,0,2.92250813368826,5.44538676806967,GNAS;CALM2,KEGG_2019_Mouse,yellow
Systemic lupus erythematosus,2/143,0.160416714470738,0.272535923509427,0,0,2.85989289332754,5.23354789527023,H3F3B;H2AFZ,KEGG_2019_Mouse,yellow
Renin-angiotensin system,1/36,0.165238740567014,0.27774171286796,0,0,5.73304473304473,10.3215669941692,ATP6AP2,KEGG_2019_Mouse,yellow
Adrenergic signaling in cardiomyocytes,2/148,0.169239108858938,0.278558289239204,0,0,2.76125244618395,4.90520680248974,GNAS;CALM2,KEGG_2019_Mouse,yellow
"Alanine, aspartate and glutamate metabolism",1/37,0.169420067180126,0.278558289239204,0,0,5.57351290684624,9.89507014564132,GOT1,KEGG_2019_Mouse,yellow
Phospholipase D signaling pathway,2/149,0.171013633267106,0.278558289239204,0,0,2.74232958489518,4.84298695199844,ARF1;GNAS,KEGG_2019_Mouse,yellow
mTOR signaling pathway,2/154,0.179932321463797,0.290094967257958,0,0,2.65145005370569,4.54769949538142,ATP6V1A;ATP6V1D,KEGG_2019_Mouse,yellow
Ferroptosis,1/40,0.181840038445641,0.290209354286982,0,0,5.14400414400414,8.76861291991989,PRNP,KEGG_2019_Mouse,yellow
Hippo signaling pathway,2/159,0.188921090423562,0.298495322869228,0,0,2.56635902768751,4.27664705514897,YWHAE;ACTG1,KEGG_2019_Mouse,yellow
Vasopressin-regulated water reabsorption,1/43,0.19407611900782,0.303604225774609,0,0,4.77585377585378,7.83003533696715,GNAS,KEGG_2019_Mouse,yellow
RNA transport,2/167,0.203427034299401,0.315112464895151,0,0,2.44094001236858,3.88706977769903,EEF1A1;EIF3C,KEGG_2019_Mouse,yellow
Type II diabetes mellitus,1/48,0.214068244088033,0.325219063133743,0,0,4.26670964968837,6.57696403663591,PKM,KEGG_2019_Mouse,yellow
Cocaine addiction,1/48,0.214068244088033,0.325219063133743,0,0,4.26670964968837,6.57696403663591,GNAS,KEGG_2019_Mouse,yellow
Cholesterol metabolism,1/49,0.21800735103248,0.328049156791732,0,0,4.17760942760943,6.36344537186664,VDAC1,KEGG_2019_Mouse,yellow
Arginine and proline metabolism,1/50,0.221926911560385,0.330126738084442,0,0,4.09214594928881,6.16034588762116,GOT1,KEGG_2019_Mouse,yellow
Tuberculosis,2/178,0.223566841614148,0.330126738084442,0,0,2.28710575139147,3.42618697401597,CALM2;ATP6V0C,KEGG_2019_Mouse,yellow
Axon guidance,2/180,0.227247144429194,0.332454155739006,0,0,2.26117862875487,3.35042706699839,CFL1;MYL12B,KEGG_2019_Mouse,yellow
Transcriptional misregulation in cancer,2/183,0.232775941528175,0.337418337261025,0,0,2.22336227308603,3.24094830013958,H3F3B;TSPAN7,KEGG_2019_Mouse,yellow
Regulation of lipolysis in adipocytes,1/56,0.245039143568043,0.351965315306826,0,0,3.64462809917355,5.12557648253206,GNAS,KEGG_2019_Mouse,yellow
Ovarian steroidogenesis,1/57,0.248824541413001,0.354182680569857,0,0,3.57936507936508,4.97892289699759,GNAS,KEGG_2019_Mouse,yellow
Focal adhesion,2/199,0.262374132122319,0.368823932095316,0,0,2.04112711074277,2.73099502551452,ACTG1;MYL12B,KEGG_2019_Mouse,yellow
Long-term depression,1/61,0.263779141308675,0.368823932095316,0,0,3.34006734006734,4.45111773409346,GNAS,KEGG_2019_Mouse,yellow
Central carbon metabolism in cancer,1/64,0.274801310842782,0.380864974676838,0,0,3.18053551386885,4.10831982313615,PKM,KEGG_2019_Mouse,yellow
cAMP signaling pathway,2/211,0.284608511779544,0.389088743015333,0,0,1.92276144907724,2.41622026619919,GNAS;CALM2,KEGG_2019_Mouse,yellow
Long-term potentiation,1/67,0.285660089808726,0.389088743015333,0,0,3.03550658096113,3.80334608196671,CALM2,KEGG_2019_Mouse,yellow
Type I diabetes mellitus,1/69,0.29280968888067,0.392067210535134,0,0,2.94592988710636,3.61828655610275,CPE,KEGG_2019_Mouse,yellow
Cortisol synthesis and secretion,1/69,0.29280968888067,0.392067210535134,0,0,2.94592988710636,3.61828655610275,GNAS,KEGG_2019_Mouse,yellow
Adherens junction,1/72,0.303401461859655,0.396177115486161,0,0,2.82102717313985,3.36463457832852,ACTG1,KEGG_2019_Mouse,yellow
Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.303401461859655,0.396177115486161,0,0,2.82102717313985,3.36463457832852,ACTG1,KEGG_2019_Mouse,yellow
Bile secretion,1/72,0.303401461859655,0.396177115486161,0,0,2.82102717313985,3.36463457832852,GNAS,KEGG_2019_Mouse,yellow
Inositol phosphate metabolism,1/73,0.306897033111884,0.397456813374407,0,0,2.78170594837262,3.28587063696556,TPI1,KEGG_2019_Mouse,yellow
Bacterial invasion of epithelial cells,1/74,0.310375237892897,0.398693395016892,0,0,2.74346201743462,3.20977722405069,ACTG1,KEGG_2019_Mouse,yellow
Glioma,1/75,0.313836161648445,0.399888012423019,0,0,2.70625170625171,3.13623236372496,CALM2,KEGG_2019_Mouse,yellow
Viral carcinogenesis,2/229,0.317832714689276,0.401740551367245,0,0,1.76867751505889,2.02731138559266,YWHAE;PKM,KEGG_2019_Mouse,yellow
Salmonella infection,1/78,0.324116094429913,0.404549050324389,0,0,2.60041978223796,2.92977207832515,ACTG1,KEGG_2019_Mouse,yellow
Ras signaling pathway,2/233,0.325175502475933,0.404549050324389,0,0,1.73769767647319,1.95211260075993,GNG3;CALM2,KEGG_2019_Mouse,yellow
RNA degradation,1/83,0.340911546721369,0.420600576652964,0,0,2.44124168514412,2.62709885646942,ENO1,KEGG_2019_Mouse,yellow
Human T-cell leukemia virus 1 infection,2/245,0.347077845012811,0.420600576652964,0,0,1.65087763500462,1.74696892731275,VDAC1;SLC25A4,KEGG_2019_Mouse,yellow
Hypertrophic cardiomyopathy (HCM),1/86,0.350789788685405,0.420600576652964,0,0,2.35472370766488,2.46673350535558,ACTG1,KEGG_2019_Mouse,yellow
Insulin secretion,1/86,0.350789788685405,0.420600576652964,0,0,2.35472370766488,2.46673350535558,GNAS,KEGG_2019_Mouse,yellow
Viral myocarditis,1/87,0.354049852499014,0.420600576652964,0,0,2.3272257458304,2.41639933353241,ACTG1,KEGG_2019_Mouse,yellow
Fc gamma R-mediated phagocytosis,1/87,0.354049852499014,0.420600576652964,0,0,2.3272257458304,2.41639933353241,CFL1,KEGG_2019_Mouse,yellow
TGF-beta signaling pathway,1/91,0.366928825262423,0.432647420831812,0,0,2.22334455667789,2.22909720803597,SKP1A,KEGG_2019_Mouse,yellow
Phosphatidylinositol signaling system,1/98,0.388858196397513,0.455108111339311,0,0,2.06216807247735,1.94780133547852,CALM2,KEGG_2019_Mouse,yellow
Longevity regulating pathway,1/102,0.401049842395342,0.465925552194589,0,0,1.98009800980098,1.80915528558786,HSPA8,KEGG_2019_Mouse,yellow
Chagas disease (American trypanosomiasis),1/103,0.404059939073185,0.4659961341136,0,0,1.9605862547039,1.77666767339805,GNAS,KEGG_2019_Mouse,yellow
Pancreatic secretion,1/105,0.410035274847405,0.469391370571316,0,0,1.92268842268842,1.71409996792236,GNAS,KEGG_2019_Mouse,yellow
Amoebiasis,1/106,0.413000661133786,0.469391370571316,0,0,1.9042809042809,1.68396719161278,GNAS,KEGG_2019_Mouse,yellow
"Parathyroid hormone synthesis, secretion and action",1/107,0.41595129052059,0.469391370571316,0,0,1.88622069754145,1.65456849319568,GNAS,KEGG_2019_Mouse,yellow
Toxoplasmosis,1/108,0.41888723576301,0.469391370571316,0,0,1.86849806475975,1.62588017253325,HSPA8,KEGG_2019_Mouse,yellow
C-type lectin receptor signaling pathway,1/112,0.43048561638067,0.47880543060336,0,0,1.8008008008008,1.51778940882089,CALM2,KEGG_2019_Mouse,yellow
Cholinergic synapse,1/113,0.433349218837219,0.47880543060336,0,0,1.78463203463203,1.4923295915181,GNG3,KEGG_2019_Mouse,yellow
Thyroid hormone signaling pathway,1/115,0.439033727758999,0.481717562402235,0,0,1.7531454899876,1.44315262186649,ACTG1,KEGG_2019_Mouse,yellow
FoxO signaling pathway,1/132,0.485127594032975,0.525001094912398,0,0,1.52432724188449,1.1026119616962,GABARAPL1,KEGG_2019_Mouse,yellow
Spliceosome,1/132,0.485127594032975,0.525001094912398,0,0,1.52432724188449,1.1026119616962,HSPA8,KEGG_2019_Mouse,yellow
Purine metabolism,1/136,0.49541620618668,0.532488167193847,0,0,1.47886270108492,1.03868964279636,PKM,KEGG_2019_Mouse,yellow
Ubiquitin mediated proteolysis,1/138,0.500483918197201,0.533381326350796,0,0,1.45712600457126,1.00859320422095,SKP1A,KEGG_2019_Mouse,yellow
Insulin signaling pathway,1/139,0.502998845735877,0.533381326350796,0,0,1.44649392475479,0.993983474661611,CALM2,KEGG_2019_Mouse,yellow
Measles,1/144,0.515386675547343,0.542873964909868,0,0,1.39556403192767,0.925032639771104,HSPA8,KEGG_2019_Mouse,yellow
Cushing syndrome,1/159,0.550745324592532,0.571081801636464,0,0,1.26211481907684,0.75282975911799,GNAS,KEGG_2019_Mouse,yellow
Wnt signaling pathway,1/160,0.553009592723917,0.571081801636464,0,0,1.25411346166063,0.742911645774827,SKP1A,KEGG_2019_Mouse,yellow
Hepatitis C,1/160,0.553009592723917,0.571081801636464,0,0,1.25411346166063,0.742911645774827,YWHAE,KEGG_2019_Mouse,yellow
Hepatocellular carcinoma,1/171,0.577182984911913,0.592174750753781,0,0,1.17231134878194,0.644297547374328,ACTG1,KEGG_2019_Mouse,yellow
Chemokine signaling pathway,1/197,0.62929598455177,0.641475906833417,0,0,1.01546072974644,0.470314261452597,GNG3,KEGG_2019_Mouse,yellow
Proteoglycans in cancer,1/203,0.640388238903461,0.648598344530428,0,0,0.984998499849985,0.438994784726488,ACTG1,KEGG_2019_Mouse,yellow
MAPK signaling pathway,1/294,0.773409712864383,0.778335889379442,0,0,0.675940290274761,0.173680384477407,HSPA8,KEGG_2019_Mouse,yellow
Olfactory transduction,1/1133,0.997108021558509,0.997108021558509,0,0,0.16746975050862,0.0004850205811354,CALM2,KEGG_2019_Mouse,yellow
Long-term potentiation,5/67,2.13419841401958e-05,0.0032866655575901,0,0,16.8404074702886,181.115792542471,PPP3CA;PPP3R1;PPP1R1A;MAPK1;PLCB1,KEGG_2019_Mouse,black
VEGF signaling pathway,4/58,0.0002029154395882,0.0116329275675194,0,0,15.3132716049383,130.204479414623,PPP3CA;SHC2;PPP3R1;MAPK1,KEGG_2019_Mouse,black
cGMP-PKG signaling pathway,6/172,0.0002266154720945,0.0116329275675194,0,0,7.58805434503973,63.6808940923706,PPP3CA;PPP3R1;PPP1R12A;MAPK1;ADRB1;PLCB1,KEGG_2019_Mouse,black
Circadian rhythm,3/30,0.0004464025026044,0.0171864963502702,0,0,22.7640320733104,175.608334527758,PER3;CRY2;ARNTL,KEGG_2019_Mouse,black
Renin secretion,4/76,0.0005728566057742,0.0176439834578465,0,0,11.474537037037,85.6559860902997,PPP3CA;PPP3R1;ADRB1;PLCB1,KEGG_2019_Mouse,black
Adrenergic signaling in cardiomyocytes,5/148,0.0008879690496146,0.0227912056067759,0,0,7.27162311372838,51.0945955063028,PPP1R1A;TPM1;MAPK1;ADRB1;PLCB1,KEGG_2019_Mouse,black
Oxytocin signaling pathway,5/154,0.0010608199151585,0.0233380381334884,0,0,6.97668668315083,47.7813259349216,PPP3CA;PPP3R1;PPP1R12A;MAPK1;PLCB1,KEGG_2019_Mouse,black
Axon guidance,5/180,0.0021102611925851,0.0374814975418973,0,0,5.93233082706767,36.5487553526087,PPP3CA;PPP3R1;MAPK1;SLIT3;PDK1,KEGG_2019_Mouse,black
Glutamatergic synapse,4/114,0.0025784986150308,0.0374814975418973,0,0,7.49621212121212,44.681532028702,PPP3CA;PPP3R1;MAPK1;PLCB1,KEGG_2019_Mouse,black
Calcium signaling pathway,5/189,0.0026071788481045,0.0374814975418973,0,0,5.6395881006865,33.5526535150813,CHRM3;PPP3CA;PPP3R1;ADRB1;PLCB1,KEGG_2019_Mouse,black
Oocyte meiosis,4/116,0.0027459134764505,0.0374814975418973,0,0,7.36160714285714,43.4161196530766,PPP3CA;PPP3R1;MAPK1;YWHAH,KEGG_2019_Mouse,black
Natural killer cell mediated cytotoxicity,4/118,0.0029206361720958,0.0374814975418973,0,0,7.23172514619883,42.2040139869092,PPP3CA;SHC2;PPP3R1;MAPK1,KEGG_2019_Mouse,black
Osteoclast differentiation,4/128,0.0039092376089755,0.0463094301370948,0,0,6.64516129032258,36.8435180398777,PPP3CA;PPP3R1;FHL2;MAPK1,KEGG_2019_Mouse,black
Dopaminergic synapse,4/135,0.0047223337439316,0.0519456711832482,0,0,6.28784987277354,33.674279209969,PPP3CA;KIF5C;PLCB1;ARNTL,KEGG_2019_Mouse,black
Adherens junction,3/72,0.0056354324907242,0.054241037723221,0,0,8.88883908561183,46.0324654948436,PTPN1;MAPK1;WASF1,KEGG_2019_Mouse,black
B cell receptor signaling pathway,3/72,0.0056354324907242,0.054241037723221,0,0,8.88883908561183,46.0324654948436,PPP3CA;PPP3R1;MAPK1,KEGG_2019_Mouse,black
Phospholipase D signaling pathway,4/149,0.0066747485612657,0.0601912049162914,0,0,5.67672413793103,28.4371166854251,DGKE;SHC2;MAPK1;PLCB1,KEGG_2019_Mouse,black
Salivary secretion,3/78,0.0070353356395665,0.0601912049162914,0,0,8.17525773195876,40.5231982940018,CHRM3;ADRB1;PLCB1,KEGG_2019_Mouse,black
Gap junction,3/86,0.0091967042793181,0.0664378426024716,0,0,7.38430008694572,34.6243191824314,MAPK1;ADRB1;PLCB1,KEGG_2019_Mouse,black
Insulin secretion,3/86,0.0091967042793181,0.0664378426024716,0,0,7.38430008694572,34.6243191824314,CHRM3;CCK;PLCB1,KEGG_2019_Mouse,black
Th1 and Th2 cell differentiation,3/87,0.0094911203717816,0.0664378426024716,0,0,7.2960235640648,33.9804900436335,PPP3CA;PPP3R1;MAPK1,KEGG_2019_Mouse,black
Fc gamma R-mediated phagocytosis,3/87,0.0094911203717816,0.0664378426024716,0,0,7.2960235640648,33.9804900436335,MAPK1;ASAP1;WASF1,KEGG_2019_Mouse,black
Endocytosis,5/269,0.0113323196459291,0.0743437078677698,0,0,3.91467304625199,17.5381129741701,ACAP2;KIF5C;ASAP1;SH3GL2;RAB11FIP4,KEGG_2019_Mouse,black
Alzheimer disease,4/175,0.0115860323949771,0.0743437078677698,0,0,4.807261208577,21.4305541904363,PPP3CA;PPP3R1;MAPK1;PLCB1,KEGG_2019_Mouse,black
Tuberculosis,4/178,0.0122692683106663,0.0748038497951499,0,0,4.72365900383142,20.7872061520803,PPP3CA;PPP3R1;MAPK1;ATP6V0A1,KEGG_2019_Mouse,black
Choline metabolism in cancer,3/99,0.0134550429542985,0.0748038497951499,0,0,6.38015463917526,27.4882665567256,DGKE;MAPK1;WASF1,KEGG_2019_Mouse,black
Circadian entrainment,3/99,0.0134550429542985,0.0748038497951499,0,0,6.38015463917526,27.4882665567256,PER3;MAPK1;PLCB1,KEGG_2019_Mouse,black
T cell receptor signaling pathway,3/101,0.0141941327321631,0.0748038497951499,0,0,6.24931622133389,26.590381744701,PPP3CA;PPP3R1;MAPK1,KEGG_2019_Mouse,black
Th17 cell differentiation,3/102,0.0145721785315227,0.0748038497951499,0,0,6.18587941268354,26.1578642224501,PPP3CA;PPP3R1;MAPK1,KEGG_2019_Mouse,black
Glucagon signaling pathway,3/102,0.0145721785315227,0.0748038497951499,0,0,6.18587941268354,26.1578642224501,PPP3CA;PPP3R1;PLCB1,KEGG_2019_Mouse,black
Pancreatic secretion,3/105,0.0157404409875109,0.0781944487766672,0,0,6.00303214069133,24.9217201151844,CHRM3;CCK;PLCB1,KEGG_2019_Mouse,black
Bladder cancer,2/41,0.0178804597481127,0.0860497125377926,0,0,10.3929879644165,41.8218699251635,DAPK1;MAPK1,KEGG_2019_Mouse,black
C-type lectin receptor signaling pathway,3/112,0.0186665018739365,0.0865456268759236,0,0,5.6155301239005,22.3555641556835,PPP3CA;PPP3R1;MAPK1,KEGG_2019_Mouse,black
Cholinergic synapse,3/113,0.0191074760635156,0.0865456268759236,0,0,5.56419868791003,22.0212934005866,CHRM3;MAPK1;PLCB1,KEGG_2019_Mouse,black
Regulation of actin cytoskeleton,4/217,0.0235597522189601,0.103662909763425,0,0,3.85113458528951,14.4348821036101,CHRM3;PPP1R12A;MAPK1;WASF1,KEGG_2019_Mouse,black
Platelet activation,3/125,0.0248487630651258,0.10629748644526,0,0,5.0138583741761,18.5259424809443,PPP1R12A;MAPK1;PLCB1,KEGG_2019_Mouse,black
Amyotrophic lateral sclerosis (ALS),2/52,0.0279085775805054,0.112859009101444,0,0,8.10204081632653,28.9957554144004,PPP3CA;PPP3R1,KEGG_2019_Mouse,black
Relaxin signaling pathway,3/131,0.0280307213331603,0.112859009101444,0,0,4.77738402061856,17.0765402810598,SHC2;MAPK1;PLCB1,KEGG_2019_Mouse,black
Serotonergic synapse,3/132,0.0285811776295865,0.112859009101444,0,0,4.74011028530328,16.8511247836,GABRB3;MAPK1;PLCB1,KEGG_2019_Mouse,black
Estrogen signaling pathway,3/134,0.0296993042968676,0.11434232154294,0,0,4.66727000865665,16.4130694679225,SHC2;MAPK1;PLCB1,KEGG_2019_Mouse,black
Insulin signaling pathway,3/139,0.0325947616635109,0.121700208564647,0,0,4.49454214675561,15.3875310726011,PTPN1;SHC2;MAPK1,KEGG_2019_Mouse,black
Vascular smooth muscle contraction,3/140,0.0331909659721763,0.121700208564647,0,0,4.46150951915118,15.193570503725,PPP1R12A;MAPK1;PLCB1,KEGG_2019_Mouse,black
Long-term depression,2/61,0.0374213004237331,0.134020471284998,0,0,6.86302317537184,22.5485670061795,MAPK1;PLCB1,KEGG_2019_Mouse,black
Human cytomegalovirus infection,4/255,0.0391597439700577,0.135055500152235,0,0,3.26178618857902,10.5685329983383,PPP3CA;PPP3R1;MAPK1;PLCB1,KEGG_2019_Mouse,black
Retrograde endocannabinoid signaling,3/150,0.0394642695250037,0.135055500152235,0,0,4.15590153587208,13.4333681655865,GABRB3;MAPK1;PLCB1,KEGG_2019_Mouse,black
Central carbon metabolism in cancer,2/64,0.0408312655246501,0.136695975886872,0,0,6.52995391705069,20.8847984924896,MAPK1;PDK1,KEGG_2019_Mouse,black
Non-small cell lung cancer,2/66,0.043167352566795,0.141441963729498,0,0,6.32525510204082,19.8781944931298,EML4;MAPK1,KEGG_2019_Mouse,black
Amphetamine addiction,2/68,0.0455522545652316,0.14550183350196,0,0,6.13296227581942,18.9440774902941,PPP3CA;PPP3R1,KEGG_2019_Mouse,black
Wnt signaling pathway,3/160,0.0462960379324419,0.14550183350196,0,0,3.88922450587695,11.9504158430344,PPP3CA;PPP3R1;PLCB1,KEGG_2019_Mouse,black
Protein processing in endoplasmic reticulum,3/163,0.0484525934448119,0.149233987810021,0,0,3.81572164948454,11.5508358689141,DNAJC1;TUSC3;UGGT2,KEGG_2019_Mouse,black
Prolactin signaling pathway,2/72,0.0504637828415357,0.152380834462676,0,0,5.78134110787172,17.265971584774,SHC2;MAPK1,KEGG_2019_Mouse,black
Bacterial invasion of epithelial cells,2/74,0.0529880944930012,0.152432998717206,0,0,5.62018140589569,16.5103396024628,SHC2;WASF1,KEGG_2019_Mouse,black
Gastric acid secretion,2/74,0.0529880944930012,0.152432998717206,0,0,5.62018140589569,16.5103396024628,CHRM3;PLCB1,KEGG_2019_Mouse,black
Glioma,2/75,0.0542668897312266,0.152432998717206,0,0,5.54291305563321,16.1511673406941,SHC2;MAPK1,KEGG_2019_Mouse,black
Hepatocellular carcinoma,3/171,0.0544403566847165,0.152432998717206,0,0,3.63254786450663,10.5730738047588,SHC2;ACTL6B;MAPK1,KEGG_2019_Mouse,black
Chronic myeloid leukemia,2/76,0.0555565913641186,0.152780626251326,0,0,5.46773303916161,15.8036792136142,SHC2;MAPK1,KEGG_2019_Mouse,black
Salmonella infection,2/78,0.058168160710821,0.157156083323973,0,0,5.32330827067669,15.1417092906877,MAPK1;WASF1,KEGG_2019_Mouse,black
Cellular senescence,3/185,0.0657265644838414,0.172924866602113,0,0,3.35074204146369,9.12156457624841,PPP3CA;PPP3R1;MAPK1,KEGG_2019_Mouse,black
ErbB signaling pathway,2/84,0.0662504359060044,0.172924866602113,0,0,4.93230462916874,13.3878197311643,SHC2;MAPK1,KEGG_2019_Mouse,black
Thiamine metabolism,1/15,0.0724552331756038,0.185500326638135,0,0,14.3477633477633,37.6598138369901,AK5,KEGG_2019_Mouse,black
Dilated cardiomyopathy (DCM),2/90,0.0746819496854828,0.185500326638135,0,0,4.59461966604824,11.9208181587653,TPM1;ADRB1,KEGG_2019_Mouse,black
GnRH signaling pathway,2/90,0.0746819496854828,0.185500326638135,0,0,4.59461966604824,11.9208181587653,MAPK1;PLCB1,KEGG_2019_Mouse,black
Chemokine signaling pathway,3/197,0.076185245944446,0.186230601197535,0,0,3.1415665851844,8.08823792810062,SHC2;MAPK1;PLCB1,KEGG_2019_Mouse,black
Focal adhesion,3/199,0.0779961129096355,0.187678146688811,0,0,3.10919419314117,7.93185376487499,SHC2;PPP1R12A;MAPK1,KEGG_2019_Mouse,black
Phosphatidylinositol signaling system,2/98,0.0864201908419546,0.204749375225554,0,0,4.21003401360544,10.3084111715959,DGKE;PLCB1,KEGG_2019_Mouse,black
cAMP signaling pathway,3/211,0.0892518307965823,0.205571458747755,0,0,2.92803330689929,7.0749873945873,PPP1R12A;MAPK1;ADRB1,KEGG_2019_Mouse,black
Melanogenesis,2/100,0.0894369333512962,0.205571458747755,0,0,4.12369845897543,9.95552171579456,MAPK1;PLCB1,KEGG_2019_Mouse,black
AGE-RAGE signaling pathway in diabetic complications,2/101,0.0909569913965944,0.205990833456993,0,0,4.08183879612451,9.78567177722125,MAPK1;PLCB1,KEGG_2019_Mouse,black
Chagas disease (American trypanosomiasis),2/103,0.0940199139873013,0.20709286793957,0,0,4.00060618306729,9.45842784039207,MAPK1;PLCB1,KEGG_2019_Mouse,black
Kaposi sarcoma-associated herpesvirus infection,3/216,0.0941331217907138,0.20709286793957,0,0,2.85857412516335,6.7549401777521,PPP3CA;PPP3R1;MAPK1,KEGG_2019_Mouse,black
HIF-1 signaling pathway,2/104,0.0955625544444408,0.207276526541463,0,0,3.96118447378952,9.30075904717404,MAPK1;PDK1,KEGG_2019_Mouse,black
Neuroactive ligand-receptor interaction,4/348,0.0970585423049072,0.207597437707718,0,0,2.3687015503876,5.52485650300949,GABRB3;CHRM3;ADRB1;CCK,KEGG_2019_Mouse,black
"Parathyroid hormone synthesis, secretion and action",2/107,0.10023386700467,0.211452267379716,0,0,3.84742468415938,8.85003537243058,MAPK1;PLCB1,KEGG_2019_Mouse,black
Mannose type O-glycan biosynthesis,1/23,0.108947297836033,0.226728160361474,0,0,9.1267217630854,20.2329475165344,LARGE1,KEGG_2019_Mouse,black
Ras signaling pathway,3/233,0.111521243396595,0.228953441998582,0,0,2.64500224114747,5.80191869874108,SHC2;MAPK1;RASAL2,KEGG_2019_Mouse,black
Thyroid hormone signaling pathway,2/115,0.112990010336963,0.228953441998582,0,0,3.57359581000542,7.7920679547705,MAPK1;PLCB1,KEGG_2019_Mouse,black
Human immunodeficiency virus 1 infection,3/238,0.116856100496193,0.233712200992387,0,0,2.58806755867515,5.55609452136573,PPP3CA;PPP3R1;MAPK1,KEGG_2019_Mouse,black
Neurotrophin signaling pathway,2/121,0.122818201919793,0.242487219174976,0,0,3.39238552563883,7.11400223667125,SHC2;MAPK1,KEGG_2019_Mouse,black
Human T-cell leukemia virus 1 infection,3/245,0.124483270661605,0.242663590909964,0,0,2.51231149356735,5.23461189108249,PPP3CA;PPP3R1;MAPK1,KEGG_2019_Mouse,black
Collecting duct acid secretion,1/27,0.126656642302827,0.242994176726201,0,0,7.72105672105672,15.9538300108164,ATP6V0A1,KEGG_2019_Mouse,black
Sphingolipid signaling pathway,2/124,0.127808625420924,0.242994176726201,0,0,3.3084643693543,6.80624319809133,MAPK1;PLCB1,KEGG_2019_Mouse,black
Autophagy,2/130,0.137929359831855,0.259038066025679,0,0,3.15242346938776,6.24499379784287,DAPK1;MAPK1,KEGG_2019_Mouse,black
Apelin signaling pathway,2/138,0.151685215687714,0.281440038745879,0,0,2.96578631452581,5.59331833808979,MAPK1;PLCB1,KEGG_2019_Mouse,black
Prion diseases,1/34,0.156813470025957,0.287491361714254,0,0,6.08111417202326,11.2664696999635,MAPK1,KEGG_2019_Mouse,black
Breast cancer,2/147,0.167467830513668,0.303380120299295,0,0,2.78043631245602,4.96853960242873,SHC2;MAPK1,KEGG_2019_Mouse,black
Thyroid cancer,1/37,0.169420067180126,0.303380120299295,0,0,5.57351290684624,9.89507014564132,MAPK1,KEGG_2019_Mouse,black
Gastric cancer,2/150,0.172791328093857,0.303766151380345,0,0,2.72366243794815,4.7818540898178,SHC2;MAPK1,KEGG_2019_Mouse,black
Aldosterone-regulated sodium reabsorption,1/38,0.173580657931626,0.303766151380345,0,0,5.42260442260442,9.49559255823113,MAPK1,KEGG_2019_Mouse,black
African trypanosomiasis,1/39,0.17772061456847,0.307516569028589,0,0,5.27963849016481,9.12080010262218,PLCB1,KEGG_2019_Mouse,black
Nicotine addiction,1/40,0.181840038445641,0.308566304057508,0,0,5.14400414400414,8.76861291991989,GABRB3,KEGG_2019_Mouse,black
MAPK signaling pathway,3/294,0.1823346342158,0.308566304057508,0,0,2.08406844510575,3.54690032572311,PPP3CA;PPP3R1;MAPK1,KEGG_2019_Mouse,black
Cushing syndrome,2/159,0.188921090423562,0.315826630076271,0,0,2.56635902768751,4.27664705514897,MAPK1;PLCB1,KEGG_2019_Mouse,black
Hepatitis C,2/160,0.190726471409696,0.315826630076271,0,0,2.54998708344097,4.22511175710114,MAPK1;YWHAH,KEGG_2019_Mouse,black
Glycosphingolipid biosynthesis,1/45,0.202132677279174,0.331153535116945,0,0,4.55831037649219,7.28796784173202,ST3GAL5,KEGG_2019_Mouse,black
Influenza A,2/168,0.20524959092647,0.332720389501857,0,0,2.42611261372019,3.84181852553833,MAPK1;KPNA1,KEGG_2019_Mouse,black
Type II diabetes mellitus,1/48,0.214068244088033,0.343401141557887,0,0,4.26670964968837,6.57696403663591,MAPK1,KEGG_2019_Mouse,black
N-Glycan biosynthesis,1/50,0.221926911560385,0.352337570930921,0,0,4.09214594928881,6.16034588762116,TUSC3,KEGG_2019_Mouse,black
Endocrine and other factor-regulated calcium reabsorption,1/55,0.241234861655302,0.37908335402976,0,0,3.71230826786382,5.27884403782842,PLCB1,KEGG_2019_Mouse,black
Regulation of lipolysis in adipocytes,1/56,0.245039143568043,0.381172001105845,0,0,3.64462809917355,5.12557648253206,ADRB1,KEGG_2019_Mouse,black
Endometrial cancer,1/58,0.252591147960672,0.388990367859435,0,0,3.5163919900762,4.83849599837867,MAPK1,KEGG_2019_Mouse,black
Alcoholism,2/199,0.262374132122319,0.398254781975843,0,0,2.04112711074277,2.73099502551452,SHC2;MAPK1,KEGG_2019_Mouse,black
Glycerolipid metabolism,1/61,0.263779141308675,0.398254781975843,0,0,3.34006734006734,4.45111773409346,DGKE,KEGG_2019_Mouse,black
Proteoglycans in cancer,2/203,0.269787257396922,0.402613322210921,0,0,2.00010153315057,2.62037615304045,PPP1R12A;MAPK1,KEGG_2019_Mouse,black
NOD-like receptor signaling pathway,2/205,0.273493735468433,0.402613322210921,0,0,1.9801950336785,2.5672764502121,MAPK1;PLCB1,KEGG_2019_Mouse,black
Pathways in cancer,4/535,0.279216084695689,0.402613322210921,0,0,1.51985247959824,1.93898113371417,EML4;DAPK1;MAPK1;PLCB1,KEGG_2019_Mouse,black
Rap1 signaling pathway,2/209,0.280904713771957,0.402613322210921,0,0,1.94153603470374,2.46524550660258,MAPK1;PLCB1,KEGG_2019_Mouse,black
Leishmaniasis,1/67,0.285660089808726,0.402613322210921,0,0,3.03550658096113,3.80334608196671,MAPK1,KEGG_2019_Mouse,black
Fc epsilon RI signaling pathway,1/68,0.289243789255229,0.402613322210921,0,0,2.99004975124378,3.70911301693322,MAPK1,KEGG_2019_Mouse,black
Renal cell carcinoma,1/68,0.289243789255229,0.402613322210921,0,0,2.99004975124378,3.70911301693322,MAPK1,KEGG_2019_Mouse,black
Acute myeloid leukemia,1/69,0.29280968888067,0.402613322210921,0,0,2.94592988710636,3.61828655610275,MAPK1,KEGG_2019_Mouse,black
Type I diabetes mellitus,1/69,0.29280968888067,0.402613322210921,0,0,2.94592988710636,3.61828655610275,PTPRN2,KEGG_2019_Mouse,black
Cortisol synthesis and secretion,1/69,0.29280968888067,0.402613322210921,0,0,2.94592988710636,3.61828655610275,PLCB1,KEGG_2019_Mouse,black
Melanoma,1/72,0.303401461859655,0.410975157384609,0,0,2.82102717313985,3.36463457832852,MAPK1,KEGG_2019_Mouse,black
Thyroid hormone synthesis,1/73,0.306897033111884,0.410975157384609,0,0,2.78170594837262,3.28587063696556,PLCB1,KEGG_2019_Mouse,black
Inositol phosphate metabolism,1/73,0.306897033111884,0.410975157384609,0,0,2.78170594837262,3.28587063696556,PLCB1,KEGG_2019_Mouse,black
Pancreatic cancer,1/75,0.313836161648445,0.414798627645327,0,0,2.70625170625171,3.13623236372496,MAPK1,KEGG_2019_Mouse,black
Pertussis,1/76,0.317279889350664,0.414798627645327,0,0,2.67003367003367,3.0651211233087,MAPK1,KEGG_2019_Mouse,black
Viral carcinogenesis,2/229,0.317832714689276,0.414798627645327,0,0,1.76867751505889,2.02731138559266,MAPK1;YWHAH,KEGG_2019_Mouse,black
Synaptic vesicle cycle,1/77,0.320706505558706,0.41503194837009,0,0,2.6347687400319,2.99633512170869,ATP6V0A1,KEGG_2019_Mouse,black
Cardiac muscle contraction,1/78,0.324116094429913,0.415948987851722,0,0,2.60041978223796,2.92977207832515,TPM1,KEGG_2019_Mouse,black
Rheumatoid arthritis,1/84,0.344220716526821,0.438099093761408,0,0,2.41170743580382,2.57201895784243,ATP6V0A1,KEGG_2019_Mouse,black
Hypertrophic cardiomyopathy (HCM),1/86,0.350789788685405,0.441461242893853,0,0,2.35472370766488,2.46673350535558,TPM1,KEGG_2019_Mouse,black
Taste transduction,1/88,0.357293708483398,0.441461242893853,0,0,2.30035992104958,2.36752381170365,CHRM3,KEGG_2019_Mouse,black
Colorectal cancer,1/88,0.357293708483398,0.441461242893853,0,0,2.30035992104958,2.36752381170365,MAPK1,KEGG_2019_Mouse,black
GABAergic synapse,1/90,0.363733115678147,0.441461242893853,0,0,2.24843945068664,2.27392523969427,GABRB3,KEGG_2019_Mouse,black
Progesterone-mediated oocyte maturation,1/90,0.363733115678147,0.441461242893853,0,0,2.24843945068664,2.27392523969427,MAPK1,KEGG_2019_Mouse,black
TGF-beta signaling pathway,1/91,0.366928825262423,0.441461242893853,0,0,2.22334455667789,2.22909720803597,MAPK1,KEGG_2019_Mouse,black
IL-17 signaling pathway,1/91,0.366928825262423,0.441461242893853,0,0,2.22334455667789,2.22909720803597,MAPK1,KEGG_2019_Mouse,black
Morphine addiction,1/92,0.370108643786799,0.44183512514083,0,0,2.1988011988012,2.18551754723327,GABRB3,KEGG_2019_Mouse,black
Glycerophospholipid metabolism,1/97,0.385772094842852,0.453503073326712,0,0,2.08375420875421,1.98479362024731,DGKE,KEGG_2019_Mouse,black
Prostate cancer,1/97,0.385772094842852,0.453503073326712,0,0,2.08375420875421,1.98479362024731,MAPK1,KEGG_2019_Mouse,black
Toll-like receptor signaling pathway,1/99,0.391928946523868,0.45725043761118,0,0,2.0410224695939,1.91177413897195,MAPK1,KEGG_2019_Mouse,black
Aldosterone synthesis and secretion,1/102,0.401049842395342,0.464373501720923,0,0,1.98009800980098,1.80915528558786,PLCB1,KEGG_2019_Mouse,black
Amoebiasis,1/106,0.413000661133786,0.474642550855246,0,0,1.9042809042809,1.68396719161278,PLCB1,KEGG_2019_Mouse,black
Toxoplasmosis,1/108,0.41888723576301,0.477417268923682,0,0,1.86849806475975,1.62588017253325,MAPK1,KEGG_2019_Mouse,black
TNF signaling pathway,1/110,0.424715362613925,0.477417268923682,0,0,1.83402835696414,1.57054463447437,MAPK1,KEGG_2019_Mouse,black
Insulin resistance,1/110,0.424715362613925,0.477417268923682,0,0,1.83402835696414,1.57054463447437,PTPN1,KEGG_2019_Mouse,black
Cell cycle,1/123,0.461212676190375,0.513986940214791,0,0,1.63752276867031,1.26727232996582,YWHAH,KEGG_2019_Mouse,black
Lysosome,1/124,0.463923277206856,0.513986940214791,0,0,1.62412745339575,1.2473885010387,ATP6V0A1,KEGG_2019_Mouse,black
Inflammatory mediator regulation of TRP channels,1/127,0.471974339207137,0.519171773127851,0,0,1.58521725188392,1.19022971699885,PLCB1,KEGG_2019_Mouse,black
FoxO signaling pathway,1/132,0.485127594032975,0.529855670078569,0,0,1.52432724188449,1.1026119616962,MAPK1,KEGG_2019_Mouse,black
Oxidative phosphorylation,1/134,0.490297600070642,0.531731200076612,0,0,1.50125313283208,1.07000724904239,ATP6V0A1,KEGG_2019_Mouse,black
Purine metabolism,1/136,0.49541620618668,0.532536697561777,0,0,1.47886270108492,1.03868964279636,AK5,KEGG_2019_Mouse,black
Signaling pathways regulating pluripotency of stem cells,1/137,0.497956392525298,0.532536697561777,0,0,1.46791443850267,1.02349273069514,MAPK1,KEGG_2019_Mouse,black
Apoptosis,1/141,0.507991154544595,0.539521639999087,0,0,1.42568542568543,0.965604255328444,MAPK1,KEGG_2019_Mouse,black
PI3K-Akt signaling pathway,2/357,0.535383524596221,0.561801571178623,0,0,1.12359873526876,0.701992939715793,MAPK1;YWHAH,KEGG_2019_Mouse,black
mTOR signaling pathway,1/154,0.539252532966754,0.561801571178623,0,0,1.30369049976893,0.805121832204194,MAPK1,KEGG_2019_Mouse,black
Human papillomavirus infection,2/360,0.53991319827556,0.561801571178623,0,0,1.11401208528104,0.686617891179883,MAPK1;ATP6V0A1,KEGG_2019_Mouse,black
Hippo signaling pathway,1/159,0.550745324592532,0.569226711323825,0,0,1.26211481907684,0.75282975911799,YWHAH,KEGG_2019_Mouse,black
Hepatitis B,1/163,0.559734829149778,0.574661091260439,0,0,1.23070208255393,0.714166728910465,MAPK1,KEGG_2019_Mouse,black
Phagosome,1/180,0.595994889569521,0.607835847640439,0,0,1.11286044805598,0.57593108520923,ATP6V0A1,KEGG_2019_Mouse,black
Huntington disease,1/192,0.619794203522166,0.627949390410615,0,0,1.04230789571104,0.498606520241977,PLCB1,KEGG_2019_Mouse,black
Thermogenesis,1/231,0.687959009576293,0.69245547369117,0,0,0.863855950812473,0.323104604801154,ACTL6B,KEGG_2019_Mouse,black
MicroRNAs in cancer,1/281,0.757922669215417,0.757922669215417,0,0,0.707792207792208,0.196181539398202,TPM1,KEGG_2019_Mouse,black
Axon guidance,4/180,0.0026476345889915,0.206515497941337,0,0,7.48484848484848,44.4157544074026,CAMK2D;EPHA6;SRGAP3;EPHA3,KEGG_2019_Mouse,pink
Long-term potentiation,2/67,0.0195020808738872,0.525908538054541,0,0,9.86153846153846,38.8271855844182,CAMK2D;GRM1,KEGG_2019_Mouse,pink
Rap1 signaling pathway,3/209,0.0294119228222651,0.525908538054541,0,0,4.71032946044883,16.6102945448027,TIAM1;CNR1;MAP2K6,KEGG_2019_Mouse,pink
Insulin secretion,2/86,0.0310166267385095,0.525908538054541,0,0,7.62365591397849,26.4787247006444,CAMK2D;KCNN3,KEGG_2019_Mouse,pink
GnRH signaling pathway,2/90,0.033712085772727,0.525908538054541,0,0,7.27565982404692,24.6637510716616,CAMK2D;MAP2K6,KEGG_2019_Mouse,pink
Primary bile acid biosynthesis,1/16,0.0500074302501758,0.530182031455642,0,0,21.0804232804233,63.1481719377084,CYP7B1,KEGG_2019_Mouse,pink
Pantothenate and CoA biosynthesis,1/18,0.0560826445470321,0.530182031455642,0,0,18.5985060690943,53.5809732719597,DPYD,KEGG_2019_Mouse,pink
Inflammatory mediator regulation of TRP channels,2/127,0.0625014772656505,0.530182031455642,0,0,5.11251612903226,14.1747837223405,CAMK2D;MAP2K6,KEGG_2019_Mouse,pink
Terpenoid backbone biosynthesis,1/23,0.0711038674321035,0.530182031455642,0,0,14.3679653679654,37.983347923908,GGPS1,KEGG_2019_Mouse,pink
Retrograde endocannabinoid signaling,2/150,0.0833639098616836,0.530182031455642,0,0,4.3129904097646,10.7157963246694,CNR1;GRM1,KEGG_2019_Mouse,pink
beta-Alanine metabolism,1/32,0.0975513931445902,0.530182031455642,0,0,10.1920122887865,23.7206440860787,DPYD,KEGG_2019_Mouse,pink
Neuroactive ligand-receptor interaction,3/348,0.100446031142208,0.530182031455642,0,0,2.79272986457591,6.41806940750073,GLRA3;CNR1;GRM1,KEGG_2019_Mouse,pink
Aldosterone-regulated sodium reabsorption,1/38,0.114769816613364,0.530182031455642,0,0,8.53667953667954,18.4804322270239,NR3C2,KEGG_2019_Mouse,pink
Calcium signaling pathway,2/189,0.122643816383237,0.530182031455642,0,0,3.40676211833707,7.14899125821178,CAMK2D;GRM1,KEGG_2019_Mouse,pink
Proteoglycans in cancer,2/203,0.137678944575236,0.530182031455642,0,0,3.16722837425774,6.28007794859158,TIAM1;CAMK2D,KEGG_2019_Mouse,pink
cAMP signaling pathway,2/211,0.146447221275615,0.530182031455642,0,0,3.04475999382621,5.84925852388414,TIAM1;CAMK2D,KEGG_2019_Mouse,pink
Amyotrophic lateral sclerosis (ALS),1/52,0.153698469136194,0.530182031455642,0,0,6.18892001244942,11.5903778629303,MAP2K6,KEGG_2019_Mouse,pink
Glycosaminoglycan biosynthesis,1/53,0.156413689629332,0.530182031455642,0,0,6.06959706959707,11.260625578367,HS6ST2,KEGG_2019_Mouse,pink
Pyrimidine metabolism,1/58,0.169861689308519,0.530182031455642,0,0,5.53578390420496,9.81367586883873,DPYD,KEGG_2019_Mouse,pink
Long-term depression,1/61,0.177828959166418,0.530182031455642,0,0,5.25820105820106,9.08056142343472,GRM1,KEGG_2019_Mouse,pink
Amphetamine addiction,1/68,0.196127699363288,0.530182031455642,0,0,4.70717839374556,7.66794325797195,CAMK2D,KEGG_2019_Mouse,pink
Fc epsilon RI signaling pathway,1/68,0.196127699363288,0.530182031455642,0,0,4.70717839374556,7.66794325797195,MAP2K6,KEGG_2019_Mouse,pink
Gastric acid secretion,1/74,0.211492805512802,0.530182031455642,0,0,4.31898238747554,6.70981683898243,CAMK2D,KEGG_2019_Mouse,pink
Glioma,1/75,0.214025395492633,0.530182031455642,0,0,4.26040326040326,6.56809584869789,CAMK2D,KEGG_2019_Mouse,pink
ErbB signaling pathway,1/84,0.236461333933823,0.530182031455642,0,0,3.79671065213234,5.47474505088422,CAMK2D,KEGG_2019_Mouse,pink
Gap junction,1/86,0.241360822806525,0.530182031455642,0,0,3.70700280112045,5.26936463546247,GRM1,KEGG_2019_Mouse,pink
Taste transduction,1/88,0.246229360662391,0.530182031455642,0,0,3.62141944900566,5.07538972374789,GRM1,KEGG_2019_Mouse,pink
Steroid hormone biosynthesis,1/89,0.248652083146247,0.530182031455642,0,0,3.58008658008658,4.98240869895167,CYP7B1,KEGG_2019_Mouse,pink
GABAergic synapse,1/90,0.251067139961744,0.530182031455642,0,0,3.53968253968254,4.8919647542576,HAP1,KEGG_2019_Mouse,pink
Toll-like receptor signaling pathway,1/99,0.272461609986622,0.530182031455642,0,0,3.21315192743764,4.17792507089814,MAP2K6,KEGG_2019_Mouse,pink
Circadian entrainment,1/99,0.272461609986622,0.530182031455642,0,0,3.21315192743764,4.17792507089814,CAMK2D,KEGG_2019_Mouse,pink
Melanogenesis,1/100,0.274801310842782,0.530182031455642,0,0,3.18053551386885,4.10831982313615,CAMK2D,KEGG_2019_Mouse,pink
Aldosterone synthesis and secretion,1/102,0.279458514358394,0.530182031455642,0,0,3.11724029545812,3.97417409617889,CAMK2D,KEGG_2019_Mouse,pink
Glucagon signaling pathway,1/102,0.279458514358394,0.530182031455642,0,0,3.11724029545812,3.97417409617889,CAMK2D,KEGG_2019_Mouse,pink
HIF-1 signaling pathway,1/104,0.284086273780162,0.530182031455642,0,0,3.05640314378178,3.84641399454936,CAMK2D,KEGG_2019_Mouse,pink
Toxoplasmosis,1/108,0.293254192117286,0.530182031455642,0,0,2.94155169856104,3.60844705144125,MAP2K6,KEGG_2019_Mouse,pink
TNF signaling pathway,1/110,0.297794714085332,0.530182031455642,0,0,2.8872870249017,3.49751776149773,MAP2K6,KEGG_2019_Mouse,pink
Cholinergic synapse,1/113,0.304551706814851,0.530182031455642,0,0,2.80952380952381,3.34028330679081,CAMK2D,KEGG_2019_Mouse,pink
Drug metabolism,1/114,0.30678978299389,0.530182031455642,0,0,2.78452029779463,3.29016833307641,DPYD,KEGG_2019_Mouse,pink
Glutamatergic synapse,1/114,0.30678978299389,0.530182031455642,0,0,2.78452029779463,3.29016833307641,GRM1,KEGG_2019_Mouse,pink
Oocyte meiosis,1/116,0.311244686347937,0.530182031455642,0,0,2.73581780538302,3.1931806183263,CAMK2D,KEGG_2019_Mouse,pink
Neurotrophin signaling pathway,1/121,0.322259019512488,0.530182031455642,0,0,2.62116402116402,2.96820521590434,CAMK2D,KEGG_2019_Mouse,pink
Osteoclast differentiation,1/128,0.337388328914785,0.530182031455642,0,0,2.47581552305962,2.69002481694602,MAP2K6,KEGG_2019_Mouse,pink
FoxO signaling pathway,1/132,0.345883864675908,0.530182031455642,0,0,2.39973343026778,2.54768230323889,GRM1,KEGG_2019_Mouse,pink
Spliceosome,1/132,0.345883864675908,0.530182031455642,0,0,2.39973343026778,2.54768230323889,SF3B3,KEGG_2019_Mouse,pink
Estrogen signaling pathway,1/134,0.350091332617861,0.530182031455642,0,0,2.36340852130326,2.48054190309761,GRM1,KEGG_2019_Mouse,pink
Dopaminergic synapse,1/135,0.352185064861568,0.530182031455642,0,0,2.34565268893627,2.44791960211739,CAMK2D,KEGG_2019_Mouse,pink
Insulin signaling pathway,1/139,0.360493799892489,0.530182031455642,0,0,2.27720266850702,2.32338552513552,PRKAR1A,KEGG_2019_Mouse,pink
Fluid shear stress and atherosclerosis,1/143,0.368697612751463,0.530182031455642,0,0,2.21260898725687,2.20769356252036,MAP2K6,KEGG_2019_Mouse,pink
Adrenergic signaling in cardiomyocytes,1/148,0.378806817269554,0.530182031455642,0,0,2.13681027966742,2.07426353677103,CAMK2D,KEGG_2019_Mouse,pink
Phospholipase D signaling pathway,1/149,0.380809451439909,0.530182031455642,0,0,2.12226512226512,2.0489539278361,GRM1,KEGG_2019_Mouse,pink
Oxytocin signaling pathway,1/154,0.390727683507582,0.530182031455642,0,0,2.05239132690113,1.92872330379487,CAMK2D,KEGG_2019_Mouse,pink
Cushing syndrome,1/159,0.400489487535077,0.530182031455642,0,0,1.98693992364878,1.81818466751275,CAMK2D,KEGG_2019_Mouse,pink
Hippo signaling pathway,1/159,0.400489487535077,0.530182031455642,0,0,1.98693992364878,1.81818466751275,FAT4,KEGG_2019_Mouse,pink
Wnt signaling pathway,1/160,0.402423291340137,0.530182031455642,0,0,1.97434361585305,1.79714781791292,CAMK2D,KEGG_2019_Mouse,pink
Protein processing in endoplasmic reticulum,1/163,0.408187935820196,0.530182031455642,0,0,1.93748775230257,1.73604246899627,WFS1,KEGG_2019_Mouse,pink
Hepatitis B,1/163,0.408187935820196,0.530182031455642,0,0,1.93748775230257,1.73604246899627,MAP2K6,KEGG_2019_Mouse,pink
JAK-STAT signaling pathway,1/164,0.410097292094483,0.530182031455642,0,0,1.92550394390885,1.7163188314336,FHL1,KEGG_2019_Mouse,pink
Tight junction,1/167,0.415789051506965,0.530182031455642,0,0,1.89041881812966,1.6589885195139,TIAM1,KEGG_2019_Mouse,pink
Influenza A,1/168,0.417674264467587,0.530182031455642,0,0,1.87900389696797,1.6404707819286,MAP2K6,KEGG_2019_Mouse,pink
Cell adhesion molecules (CAMs),1/170,0.421426742951921,0.530182031455642,0,0,1.85657931811778,1.60428748740981,ALCAM,KEGG_2019_Mouse,pink
Ribosome,1/170,0.421426742951921,0.530182031455642,0,0,1.85657931811778,1.60428748740981,MRPS17,KEGG_2019_Mouse,pink
Necroptosis,1/176,0.43254193956089,0.531618853035814,0,0,1.79238095238095,1.50215143615625,CAMK2D,KEGG_2019_Mouse,pink
Tuberculosis,1/178,0.436200084542207,0.531618853035814,0,0,1.77194870415209,1.47010474022245,CAMK2D,KEGG_2019_Mouse,pink
Cellular senescence,1/185,0.448821712900204,0.538586055480245,0,0,1.70393374741201,1.36507166954898,MAP2K6,KEGG_2019_Mouse,pink
Huntington disease,1/192,0.461165101165301,0.545013301377174,0,0,1.6409041801712,1.27005846215229,HAP1,KEGG_2019_Mouse,pink
Chemokine signaling pathway,1/197,0.469814806073432,0.546948580204891,0,0,1.59863945578231,1.20763892868292,TIAM1,KEGG_2019_Mouse,pink
Kaposi sarcoma-associated herpesvirus infection,1/216,0.501454821076242,0.568685090036248,0,0,1.45596160944998,1.00496550849181,MAP2K6,KEGG_2019_Mouse,pink
Regulation of actin cytoskeleton,1/217,0.50306757964745,0.568685090036248,0,0,1.44914756025867,0.995608956532769,TIAM1,KEGG_2019_Mouse,pink
Epstein-Barr virus infection,1/229,0.522024649735457,0.572199399599657,0,0,1.37204121414648,0.891882316387758,MAP2K6,KEGG_2019_Mouse,pink
Thermogenesis,1/231,0.525114185516825,0.572199399599657,0,0,1.359972394755,0.876011997961015,CNR1,KEGG_2019_Mouse,pink
Ras signaling pathway,1/233,0.528184061168914,0.572199399599657,0,0,1.34811165845649,0.860513766537332,TIAM1,KEGG_2019_Mouse,pink
Human immunodeficiency virus 1 infection,1/238,0.535773543206806,0.572470361234669,0,0,1.31933561047485,0.823323077491272,MAP2K6,KEGG_2019_Mouse,pink
Human cytomegalovirus infection,1/255,0.560689802472349,0.590997359362746,0,0,1.2299712535933,0.711645947369856,MAP2K6,KEGG_2019_Mouse,pink
MAPK signaling pathway,1/294,0.612983670739299,0.637503017568871,0,0,1.06414215287935,0.520809240532874,MAP2K6,KEGG_2019_Mouse,pink
Herpes simplex virus 1 infection,1/433,0.754154119863678,0.774000280912722,0,0,0.716637272192828,0.202205318447744,ZFP956,KEGG_2019_Mouse,pink
Pathways in cancer,1/535,0.824143073964047,0.834846230768774,0,0,0.576719576719577,0.111543985426523,CAMK2D,KEGG_2019_Mouse,pink
Olfactory transduction,1/1133,0.976206182149046,0.976206182149046,0,0,0.263671546357059,0.006349596502784,CAMK2D,KEGG_2019_Mouse,pink
Nicotine addiction,3/40,0.0010476950310726,0.0775294322993763,0,0,16.6032320980775,113.917477373754,GRIA1;GRIN3A;GABRA3,KEGG_2019_Mouse,red
Glutamatergic synapse,4/114,0.0025784986150308,0.0954044487561431,0,0,7.49621212121212,44.681532028702,GRIA1;GRM5;GRIN3A;GNG2,KEGG_2019_Mouse,red
Retrograde endocannabinoid signaling,4/150,0.0068317816219663,0.138460810200908,0,0,5.63755707762557,28.1098167729707,GRIA1;GRM5;GNG2;GABRA3,KEGG_2019_Mouse,red
mTOR signaling pathway,4/154,0.0074843681189679,0.138460810200908,0,0,5.48611111111111,26.8541775042426,ATP6V1G2;RRAGB;GRB10;LAMTOR4,KEGG_2019_Mouse,red
GABAergic synapse,3/90,0.0104072034150418,0.145713351208307,0,0,7.04337006754355,32.1547950435062,NSF;GNG2;GABRA3,KEGG_2019_Mouse,red
Starch and sucrose metabolism,2/33,0.0118145960439168,0.145713351208307,0,0,13.0803159973667,58.0559303610333,GPI1;GAA,KEGG_2019_Mouse,red
Vasopressin-regulated water reabsorption,2/43,0.0195637897091909,0.206817205497161,0,0,9.88501742160279,38.888398778374,NSF;DYNC1I2,KEGG_2019_Mouse,red
Long-term potentiation,2/67,0.0443537761760119,0.374540759758571,0,0,6.2276295133438,19.4025373950964,GRIA1;GRM5,KEGG_2019_Mouse,red
Amphetamine addiction,2/68,0.0455522545652316,0.374540759758571,0,0,6.13296227581942,18.9440774902941,GRIA1;GRIN3A,KEGG_2019_Mouse,red
Synaptic vesicle cycle,2/77,0.0568570608364097,0.420742250189432,0,0,5.39455782312925,15.4673563823572,NSF;ATP6V1G2,KEGG_2019_Mouse,red
Morphine addiction,2/92,0.0775653030615549,0.521802947868642,0,0,4.49206349206349,11.484567093173,GNG2;GABRA3,KEGG_2019_Mouse,red
Circadian entrainment,2/99,0.0879246283814667,0.542201875019045,0,0,4.16642120765832,10.129717084782,GRIA1;GNG2,KEGG_2019_Mouse,red
Neuroactive ligand-receptor interaction,4/348,0.0970585423049072,0.552487086966395,0,0,2.3687015503876,5.52485650300949,GRIA1;GRM5;GRIN3A;GABRA3,KEGG_2019_Mouse,red
Ras signaling pathway,3/233,0.111521243396595,0.566612516148573,0,0,2.64500224114747,5.80191869874108,GNG2;RASGRF1;PAK3,KEGG_2019_Mouse,red
Collecting duct acid secretion,1/27,0.126656642302827,0.566612516148573,0,0,7.72105672105672,15.9538300108164,ATP6V1G2,KEGG_2019_Mouse,red
Dopaminergic synapse,2/135,0.146494146719129,0.566612516148573,0,0,3.03314408470155,5.82597157350083,GRIA1;GNG2,KEGG_2019_Mouse,red
Citrate cycle (TCA cycle),1/32,0.148304021933978,0.566612516148573,0,0,6.47409579667644,12.3557529781019,IDH3B,KEGG_2019_Mouse,red
Pentose phosphate pathway,1/32,0.148304021933978,0.566612516148573,0,0,6.47409579667644,12.3557529781019,GPI1,KEGG_2019_Mouse,red
Galactose metabolism,1/32,0.148304021933978,0.566612516148573,0,0,6.47409579667644,12.3557529781019,GAA,KEGG_2019_Mouse,red
"Alanine, aspartate and glutamate metabolism",1/37,0.169420067180126,0.566612516148573,0,0,5.57351290684624,9.89507014564132,ASNS,KEGG_2019_Mouse,red
Phospholipase D signaling pathway,2/149,0.171013633267106,0.566612516148573,0,0,2.74232958489518,4.84298695199844,DGKG;GRM5,KEGG_2019_Mouse,red
Glycosphingolipid biosynthesis,1/45,0.202132677279174,0.566612516148573,0,0,4.55831037649219,7.28796784173202,ST6GALNAC5,KEGG_2019_Mouse,red
Proteasome,1/46,0.206131004383124,0.566612516148573,0,0,4.45679012345679,7.03835624820852,PSMA1,KEGG_2019_Mouse,red
Cocaine addiction,1/48,0.214068244088033,0.566612516148573,0,0,4.26670964968837,6.57696403663591,GRIN3A,KEGG_2019_Mouse,red
Amino sugar and nucleotide sugar metabolism,1/49,0.21800735103248,0.566612516148573,0,0,4.17760942760943,6.36344537186664,GPI1,KEGG_2019_Mouse,red
Arginine and proline metabolism,1/50,0.221926911560385,0.566612516148573,0,0,4.09214594928881,6.16034588762116,CKMT1,KEGG_2019_Mouse,red
N-Glycan biosynthesis,1/50,0.221926911560385,0.566612516148573,0,0,4.09214594928881,6.16034588762116,ALG2,KEGG_2019_Mouse,red
Axon guidance,2/180,0.227247144429194,0.566612516148573,0,0,2.26117862875487,3.35042706699839,PAK3;ROBO1,KEGG_2019_Mouse,red
Phagosome,2/180,0.227247144429194,0.566612516148573,0,0,2.26117862875487,3.35042706699839,DYNC1I2;ATP6V1G2,KEGG_2019_Mouse,red
Amyotrophic lateral sclerosis (ALS),1/52,0.229707776816989,0.566612516148573,0,0,3.93127351950881,5.78269622196604,GRIA1,KEGG_2019_Mouse,red
Alcoholism,2/199,0.262374132122319,0.574107542848293,0,0,2.04112711074277,2.73099502551452,GRIN3A;GNG2,KEGG_2019_Mouse,red
Focal adhesion,2/199,0.262374132122319,0.574107542848293,0,0,2.04112711074277,2.73099502551452,RASGRF1;PAK3,KEGG_2019_Mouse,red
Long-term depression,1/61,0.263779141308675,0.574107542848293,0,0,3.34006734006734,4.45111773409346,GRIA1,KEGG_2019_Mouse,red
Glycerolipid metabolism,1/61,0.263779141308675,0.574107542848293,0,0,3.34006734006734,4.45111773409346,DGKG,KEGG_2019_Mouse,red
cAMP signaling pathway,2/211,0.284608511779544,0.578487578510457,0,0,1.92276144907724,2.41622026619919,GRIA1;GRIN3A,KEGG_2019_Mouse,red
Glycolysis / Gluconeogenesis,1/67,0.285660089808726,0.578487578510457,0,0,3.03550658096113,3.80334608196671,GPI1,KEGG_2019_Mouse,red
Renal cell carcinoma,1/68,0.289243789255229,0.578487578510457,0,0,2.99004975124378,3.70911301693322,PAK3,KEGG_2019_Mouse,red
Salmonella infection,1/78,0.324116094429913,0.614877544831894,0,0,2.60041978223796,2.92977207832515,DYNC1I2,KEGG_2019_Mouse,red
Human immunodeficiency virus 1 infection,2/238,0.334326152614819,0.614877544831894,0,0,1.70044967139398,1.86307771517288,GNG2;PAK3,KEGG_2019_Mouse,red
ErbB signaling pathway,1/84,0.344220716526821,0.614877544831894,0,0,2.41170743580382,2.57201895784243,PAK3,KEGG_2019_Mouse,red
Rheumatoid arthritis,1/84,0.344220716526821,0.614877544831894,0,0,2.41170743580382,2.57201895784243,ATP6V1G2,KEGG_2019_Mouse,red
Gap junction,1/86,0.350789788685405,0.614877544831894,0,0,2.35472370766488,2.46673350535558,GRM5,KEGG_2019_Mouse,red
Taste transduction,1/88,0.357293708483398,0.614877544831894,0,0,2.30035992104958,2.36752381170365,GABRA3,KEGG_2019_Mouse,red
Glycerophospholipid metabolism,1/97,0.385772094842852,0.614949532291992,0,0,2.08375420875421,1.98479362024731,DGKG,KEGG_2019_Mouse,red
Phosphatidylinositol signaling system,1/98,0.388858196397513,0.614949532291992,0,0,2.06216807247735,1.94780133547852,DGKG,KEGG_2019_Mouse,red
Choline metabolism in cancer,1/99,0.391928946523868,0.614949532291992,0,0,2.0410224695939,1.91177413897195,DGKG,KEGG_2019_Mouse,red
T cell receptor signaling pathway,1/101,0.398024694482133,0.614949532291992,0,0,2.0,1.84248245836996,PAK3,KEGG_2019_Mouse,red
Cholinergic synapse,1/113,0.433349218837219,0.614949532291992,0,0,1.78463203463203,1.4923295915181,GNG2,KEGG_2019_Mouse,red
MAPK signaling pathway,2/294,0.433647407322141,0.614949532291992,0,0,1.37042214145932,1.14501990493626,PTPRR;RASGRF1,KEGG_2019_Mouse,red
Leukocyte transendothelial migration,1/115,0.439033727758999,0.614949532291992,0,0,1.7531454899876,1.44315262186649,THY1,KEGG_2019_Mouse,red
Ribosome biogenesis in eukaryotes,1/115,0.439033727758999,0.614949532291992,0,0,1.7531454899876,1.44315262186649,GNL3L,KEGG_2019_Mouse,red
Oocyte meiosis,1/116,0.441854774426629,0.614949532291992,0,0,1.73781291172596,1.41940043016639,YWHAG,KEGG_2019_Mouse,red
Neurotrophin signaling pathway,1/121,0.455750702577925,0.614949532291992,0,0,1.66498316498317,1.30835929507761,MAGED1,KEGG_2019_Mouse,red
Cell cycle,1/123,0.461212676190375,0.614949532291992,0,0,1.63752276867031,1.26727232996582,YWHAG,KEGG_2019_Mouse,red
Lysosome,1/124,0.463923277206856,0.614949532291992,0,0,1.62412745339575,1.2473885010387,GAA,KEGG_2019_Mouse,red
Autophagy,1/130,0.479905677193982,0.614949532291992,0,0,1.54811682718659,1.13657427447839,RRAGB,KEGG_2019_Mouse,red
Relaxin signaling pathway,1/131,0.482523156606063,0.614949532291992,0,0,1.53613053613054,1.11941882389327,GNG2,KEGG_2019_Mouse,red
Serotonergic synapse,1/132,0.485127594032975,0.614949532291992,0,0,1.52432724188449,1.1026119616962,GNG2,KEGG_2019_Mouse,red
Oxidative phosphorylation,1/134,0.490297600070642,0.614949532291992,0,0,1.50125313283208,1.07000724904239,ATP6V1G2,KEGG_2019_Mouse,red
Apelin signaling pathway,1/138,0.500483918197201,0.617263499109881,0,0,1.45712600457126,1.00859320422095,GNG2,KEGG_2019_Mouse,red
PI3K-Akt signaling pathway,2/357,0.535383524596221,0.649481652788858,0,0,1.12359873526876,0.701992939715793,GNG2;YWHAG,KEGG_2019_Mouse,red
Hippo signaling pathway,1/159,0.550745324592532,0.649566823199522,0,0,1.26211481907684,0.75282975911799,YWHAG,KEGG_2019_Mouse,red
Hepatitis C,1/160,0.553009592723917,0.649566823199522,0,0,1.25411346166063,0.742911645774827,YWHAG,KEGG_2019_Mouse,red
RNA transport,1/167,0.568546217907677,0.654660895049065,0,0,1.20080321285141,0.678060757672765,NUP93,KEGG_2019_Mouse,red
Cell adhesion molecules (CAMs),1/170,0.575039975380935,0.654660895049065,0,0,1.17930787161556,0.652529581961561,CNTN1,KEGG_2019_Mouse,red
Calcium signaling pathway,1/189,0.613977814396427,0.684548821800601,0,0,1.05910165484634,0.516626063848475,GRM5,KEGG_2019_Mouse,red
Huntington disease,1/192,0.619794203522166,0.684548821800601,0,0,1.04230789571104,0.498606520241977,GRM5,KEGG_2019_Mouse,red
Chemokine signaling pathway,1/197,0.62929598455177,0.684822100835749,0,0,1.01546072974644,0.470314261452597,GNG2,KEGG_2019_Mouse,red
Kaposi sarcoma-associated herpesvirus infection,1/216,0.663306734921852,0.703009064357765,0,0,0.924829692271553,0.37965900333487,GNG2,KEGG_2019_Mouse,red
Regulation of actin cytoskeleton,1/217,0.66500857439248,0.703009064357765,0,0,0.920501309390198,0.375523428864261,PAK3,KEGG_2019_Mouse,red
Viral carcinogenesis,1/229,0.684778279205045,0.713712572692582,0,0,0.871522239943293,0.330010762244593,YWHAG,KEGG_2019_Mouse,red
Human cytomegalovirus infection,1/255,0.723736859618685,0.743840661274759,0,0,0.781277340332458,0.252608375993645,GNG2,KEGG_2019_Mouse,red
Human papillomavirus infection,1/360,0.838126716029775,0.849607903920594,0,0,0.549815705804564,0.0970897438463633,ATP6V1G2,KEGG_2019_Mouse,red
Pathways in cancer,1/535,0.93400856626885,0.93400856626885,0,0,0.366322400030265,0.0250087090710907,GNG2,KEGG_2019_Mouse,red
